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The cornea is a complex, layered, transparent structure that is responsible for transmitting 
and refracting light to ensure vision. Of all the layers, the corneal endothelium is 
physiologically the most important layer. Its principle function is to regulate deturgescence, 
a requirement for corneal transparency. Corneal deturgescence is regulated by key 
functional genes that include a network of tight junctions, water channels and ion pumps. 
 
In this study, we created an in vitro model of murine corneal endothelial development by 
immortalising endothelial cells at significant stages in corneal endothelial morphogenesis. 
Primary cultures of presumptive corneal endothelial cells were immortalised from wild-
type mouse embryos at embryonic day (E) 14.5 and E15.5, and mature corneal endothelial 
cells were immortalised from wild-type pups at post-natal day (P) 13. These cell lines, 
together with already established cell lines at earlier stages in corneal endothelial 
development (E12.5 and E13.5), were used to map the expression patterns of three 
functional genes associated with corneal endothelial function, Zo1, Aqp1 and Slc4a4. 
 
Zo1 is a tight junction protein that facilitates the formation of the resilient monolayer that is 
characteristic of the corneal endothelium. Aqp1 is a water channel protein that mediates 
transcellular fluid transport while Slc4a4 is an ion pump that transports cellular bicarbonate 
ions across plasma membranes. Aqp1 and Slc4a4 are disease target genes which is 
indicative of their functional significance in corneal endothelial physiology.  
 
Quantitative real-time PCR (qPCR) and western blot analysis showed that Zo1 expression 
at both mRNA and protein level was progressively down-regulated from E12.5 to E15.5, 
after which it was up-regulated at P13 (p˂0.05 relative to E15.5 at mRNA level). Aqp1 
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gene expression was up-regulated at E13.5, with subsequent down-regulation at E14.5. 
Thereafter, Aqp1 gene expression was up-regulated at E15.5. Interestingly, Aqp1 gene 
expression was significantly down-regulated at P13 when the endothelium is completely 
matured (p˂0.05 relative to all other cell lines). Western blot analysis demonstrated Aqp1 
expression throughout development in this model. Densitometric analysis showed that 
glycosylated Aqp1 protein expression levels decreased gradually from E12.5 to P13. 
Unglycosylated Aqp1 protein expression was only present at E12.5 and E13.5, and was up-
regulated at E13.5. Slc4a4 was expressed at low levels during corneal endothelial 
development. However, it was highly expressed at P13 (p˂0.05 relative to all other cell 
lines). Protein expression for Slc4a4 could not be determined due to the lack of a 
commercially available antibody specific for murine Slc4a4. Confocal microscopy analysis 
demonstrated the protein localisation patterns for Zo1 and Aqp1 in monolayer and hanging 
drop culture, mimicking the 3D environment in which corneal endothelial development 
occurs. 
 
The results of this study provide valuable insight into the expression patterns of key 
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1. INTRODUCTION AND LITERATURE REVIEW 
1.1 The eye 
The mammalian eye is a complex sensory organ composed of an array of interdependent 
tissues that function together to ensure vision (Figure 1.1) (Kidson et al., 1999). Optimal 
functioning of the eye depends on co-ordinated interactions between the structures of the 
functionally distinct anterior and posterior segments (Reneker et al., 2000).  The anterior 
segment consists of the anterior chamber filled with aqueous humor, the lens, iris, ciliary 
body, trabecular meshwork and the cornea (Figure 1.1 A). Together, the lens and the cornea 
play a role in refracting and regulating light as it enters the eye  (Thut et al., 2001). The 
posterior segment consists of the eye muscle, hyaloid membrane, optic nerve, choroid, 
sclera, retina and vitreous humor (Figure 1.1 B). These components act to convert refracted 
light transmitted by structures of the anterior segment into electrical impulses which are 
then transduced to the brain to produce an image (Cvekl and Tamm, 2004).  
 
 
Figure 1.1: Structure of the adult human eye showing the anterior segment (A) and 
posterior segment (B). Image adapted from http://focuseye.com/facts-info/the-anatomy-of-
the-eye/.  
(A)  Anterior Segment (B) Posterior Segment  
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Light passes through the transparent cornea which serves as the first point of refraction. 
Refracted light then passes through the anterior chamber and through the opening in the iris 
(pigmented structure of the eye) known as the pupil. The iris controls the diameter of the 
pupil and thus the amount of refracted light that enters the eye. After passing through the 
cornea and the iris, light is further refracted by the lens and focused onto the retina. The 
retina is a layer of photosensitive rods and cones that convert light waves into electrical 
impulses that are transmitted to the brain by the optic nerve to produce an image. 
Preservation of the integrity and arrangement of the ocular structures in both segments is 
essential as any abnormalities can lead to impaired vision and possibly vision loss (Reneker 
et al., 2000, Araujo Silva et al., 2011).  
 
1.2 The anterior segment of the eye 
The structures of the posterior segment are functionally dependent on the structures of the 
anterior segment to ensure vision. The cornea and the lens, which provide the refractive 
power of the eye, are both avascular structures allowing for optimal transparency (Cvekl 
and Tamm, 2004). Their nutrition is derived from the aqueous humor produced by the 
ciliary bodies (Kidson et al., 1999, Cvekl and Tamm, 2004). The avascular stroma, which 
makes up 90% of the murine cornea, consists of regularly spaced collagen fibrils that 
reduce light scatter to ensure corneal transparency (Bonanno, 2012). The trabecular 
meshwork and Schlemm’s canal are involved in the outflow of aqueous humor (Cvekl and 
Tamm, 2004, Ito and Walter, 2014). The trabecular meshwork is a porous network of cells 
located between the iris and the cornea. Aqueous humor exits the eye through the trabecular 
meshwork into Schlemm’s canal, subsequently entering the venous system (Figure 1.2) 
(Kidson et al., 1999, Cvekl and Tamm, 2004).  
 
The trabecular network provides resistance to the flow of aqueous humor as it exits the eye. 
This resistance creates intraocular pressure (IOP) that is slightly greater than that of the 
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veins outside the eye. Regulated IOP is required to maintain the correct shape and curvature 
of the eye. IOP depends on the ability of the anterior segment structures to balance the 
production of aqueous humor with its exit from the eye (Thut et al., 2001). Elevated IOP 
affects the distance between the refractive surfaces of the cornea and lens, and the retina. 
Consequently, image formation is distorted and vision becomes impaired (Kidson et al., 
1999, Cvekl and Tamm, 2004). Elevated IOP is a key risk factor for glaucoma which is a 
progressive blinding condition characterized by optic nerve damage and vision loss (Thut et 
al., 2001, Ito and Walter, 2014).  
 
Figure 1.2: The flow of aqueous humor in the anterior segment of the eye. Image obtained 
from: https://www.google.co.za/search?q=aqueous+humor+outflow+pathway  
 
1.3 The cornea 
The highly specialised transparent and avascular cornea consists of six distinct layers: the 
outer epithelium, Bowman’s layer, the stroma, Dua’s layer, Descemet’s membrane and the 
corneal endothelium (Figures 1.3 and 1.4) (Kidson et al., 1999, Reneker et al., 2000).  
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Figure 1.3: Structure of the eye and layers of the mature cornea. Image adapted from 
Parekh et al. (2013).  
 
Figure 1.4: Histochemical staining of a mouse cornea (haemoatoxylin and eosin to stain the 
nuclei and membranes respectively, and periodic acid Schiff to stain mucopolysaccharides). 
EP - epithelium. S - stroma. EN - endothelium. Image adapted from Ramaldo et al. (2004).   
 
The anterior surface of the mature cornea is covered with stratified squamous 
nonkeratinised epithelium that rests firmly on Bowman’s layer, an acellular layer composed 
of collagen fibrils embedded in a matrix of glycosaminoglycans. The corneal stroma 
consists of type I collagen fibrils and keratocytes (specialised fibroblast cells) that produce 
collagen and other essential substances such as glycosaminoglycans (Flügel-Koch et al., 
2002, Macnamara et al., 2004). Glycosaminoglycans are hydrophilic proteins that control 
the regular spaces between the stromal fibrils, thus playing a role in the maintenance of 





corneal hydration and transparency, both of which are essential for optical function 
(Bonanno, 2012). The recently discovered Dua’s layer is located between the corneal 
stroma and Descemet’s membrane. Although relatively thin, Dua’s layer is a resilient 
collagenous layer that forms a barrier between stromal keratocytes and Descemet’s 
membrane (Dua et al., 2013). Descemet’s membrane is a thick elastic layer located beneath 
the stroma that serves as a basement membrane for the corneal endothelium (Bonanno, 
2012).  
 
1.4 The corneal endothelium 
The mature corneal endothelium is physiologically the most important layer of the cornea. 
It consists of a monolayer of mitotically inactive hexagonal cells (Bi et al., 2013, Kim et 
al., 2014), joined by tight junctions (Pajoohesh‐Ganji and Stepp, 2005), that form a barrier 
between the stroma and the aqueous humor in the anterior chamber (Araujo Silva et al., 
2011). Corneal deturgescence is the active physiological process of maintaining a relatively 
dehydrated state required for transparency. The corneal endothelium is responsible for 
transporting nutrients between the stroma and the aqueous humor. Nutrients that are 
pumped out of the aqueous humor into the stroma passively diffuse throughout the entire 
cornea and nourish the epithelial cells and stromal fibroblasts. Furthermore, the corneal 
endothelium is responsible for pumping out excess fluid and metabolic waste from the 
stromal and epithelial cells into the aqueous humor to prevent swelling and maintain 
deturgescence (Reneker et al., 2000, Pajoohesh‐Ganji and Stepp, 2005, Peh et al., 2011).  
 
The physical separation of the stroma and aqueous humor is important as excess fluid in the 
stroma can disrupt the organisation of the kerotocytes and collagen fibrils, which would 
reduce corneal transparency (Kidson et al., 1999, Reneker et al., 2000, Pajoohesh‐Ganji 
and Stepp, 2005). These corneal layers are collectively responsible for transmitting and 
refracting light as part of the optical system. They also form a protective barrier against 
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infections and chemical or physical injury to the eye, thus protecting the delicate intraocular 
structures (Flügel-Koch et al., 2002, Kao et al., 2008). 
 
Corneal endothelial cells have a mitochondria-rich cytoplasm that is essential for the cells 
to act as a fluid pump. They have a well-developed Golgi apparatus that is required for the 
production and transport of extracellular proteins that carry out the pump function 
(Besharse et al., 2010, Bonanno, 2012). Bowman’s layer is embedded in a matrix of 
negatively charged glycosaminoglycans that are bound to proteoglycans, causing a constant 
influx of cations into the stroma. These cations are accompanied by water due to osmosis, 
thus causing corneal stromal swelling. The regular aqueous-filled spaces between the 
collagen fibers in the stroma are necessary for entry of light and therefore transparency 
(Besharse et al., 2010). Excess water can alter the spacing between the collagen fibrils, thus 
increasing light scatter and causing opacity (Thiagarajah and Verkman, 2002, Bonanno, 
2012). Therefore, the principle function of the corneal endothelium is to regulate the pump 
function in order to maintain optimal stromal hydration and preserve transparency. 
  
The cornea is responsible for 70-75% of the refractive power of the eye (Zieske, 2004). 
This refractive power greatly depends on corneal deturgescence. Structural and/functional 
disruption of the endothelium can compromise its pump function, leading to corneal edema 
and subsequent vision loss (Macnamara et al., 2004). A minimum cell density of 
500cells/mm2 is required to actively pump fluid and nutrients from the stroma into the 
anterior chamber (Fujita et al., 2013, Parekh et al., 2013). Unlike epithelial cells that 
undergo continuous self-renewal, corneal endothelial cells do not proliferate in vivo as they 
are arrested in the G1 phase. As they are unable to proliferate, a decrease in cell density 
through aging, trauma or disease causes them to spread out to maintain a continuous 
monolayer. When the endothelial layer becomes too thin, the pump function is 
compromised and it can no longer maintain corneal deturgescence (Peh et al., 2011, Parekh 
et al., 2013).  
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1.5 Embryonic development of the anterior segment of the eye 
Embryonic development of the anterior segment depends on co-ordinated cellular events 
and precise molecular cues that direct cellular migration, proliferation and differentiation 
(Kao et al., 2008). Much of our knowledge is derived from research based on animal 
models that are genetically and physiologically similar to humans such as chick and mouse 
(Kidson et al., 1999, Reneker et al., 2000, Ittner et al., 2005).  
 
The earliest known molecular event in vertebrate eye development is the formation of the 
eye field within the anterior neural plate during gastrulation. Activation of a network of 
transcription factors within the eye field initiates anterior segment morphogenesis. 
Structures of the anterior segment are constructed from four embryonic tissues: neural 
ectoderm, surface ectoderm, neural crest and mesoderm mesenchyme (Chow and Lang, 
2001, Gage and Zacharias, 2009, Ju et al., 2012). Mesenchyme cells, derived from 
predominantly neural crest with contributions from lateral plate mesoderm, are collectively 
known as periocular mesenchyme (POM) (Beebe and Coats, 2000, Langenberg et al., 
2008).  
 
Eye development is initiated by a thickening of the neural ectoderm to form the optic pits, 
which marks the first morphologically distinct phase in anterior segment morphogenesis 
(Gage and Zacharias, 2009).  
 
In the mouse, by embryonic day (E) 9 the optic pits mature to form the optic vesicles which 
extend towards the outer surface neural ectoderm on either side of the diencephalon of the 
developing head (Figure 1.5 A) (Chow and Lang, 2001). The optic vesicle extends laterally 
until it makes contact with the outer surface ectoderm (Cvekl and Tamm, 2004, Gage and 
Zacharias, 2009). The outer surface ectoderm is a region of head ectoderm that is destined 
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to contribute to the lens, epithelia of the cornea, conjunctiva and limbus, and the eyelid 
epidermis (Chow and Lang, 2001).  Direct contact between the optic vesicle and outer 
surface ectoderm induces the formation of the lens placode from a region of competent 
surface ectoderm (Cvekl and Tamm, 2004).  
 
At E10, the lens placode invaginates towards the head midline to form the lens pit and 
eventually detaches from the surrounding surface ectoderm to form the lens vesicle (fated 
to become the mature lens) by E11 (Reneker et al., 2000, Gage and Zacharias, 2009). Lens 
development has been well characterized by Chow and Lang (2001). As the lens vesicle 
forms, the optic vesicle is transformed into the optic cup (Figure 1.5 B) (Cvekl and Tamm, 
2004, Gage and Zacharias, 2009). The inner layer of the optic cup will form the retina and 
the outer layer will form the pigmented retinal epithelium. Furthermore, cells lining the 
anterior surface of the optic cup will ultimately become the epithelial cells of the ciliary 
body and the iris (Figure 1.5 C and D) (Thut et al., 2001, Cvekl and Tamm, 2004, Gage and 
Zacharias, 2009).  
 
Figure 1.5: Schematic diagram of murine eye development. Image adapted from Thut et al., 
2001.  
A B C D 
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From E12, POM cells of predominantly neural crest derivation migrate between the 
anterior portion of the developing lens and the surface ectoderm (Figure 1.6). This region of 
the surface ectoderm will mature into the corneal epithelium. Between E12.5 and E13.5, 
POM cells that cover the anterior lens and optic cup respond to signals from the developing 
lens and surrounding cells, thereby initiating corneal endothelial development by a process 
of mesenchyme-to-epithelial transition (Thut et al., 2001, Gage et al., 2005). 
 
  
Figure 1.6: Cell migration patterns in the developing eye. Neural crest cells are shown in 
green and mesodermal cells are shown in red. Image adapted from Besharse et al., 2010.  
 
Between E13.5 and E14.5, the developing corneal endothelium dissociates from the lens. 
The resultant space between the corneal endothelium and the lens will become the fluid-
filled anterior chamber. By E15, corneal endothelial precursor cells mature to form tight 
junctions and eventually develop into a monolayer of corneal endothelial cells (Gage and 
Zacharias, 2009). POM cells between the presumptive corneal epithelium and differentiated 
corneal endothelium differentiate into stromal keratocytes. By late gestation in the mouse, 
these stromal keratocytes begin to synthesise collagen and produce an extracellular matrix 
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(ECM) that is required to maintain corneal transparency. Precursor cells of the ciliary body 
and iris migrate into the angle between the iris and the cornea, known as the iridocorneal 
angle. Once the cornea is completely separated from the lens, these precursor cells become 
pigmented and mature into the epithelial cells of the ciliary body and the iris (Cvekl and 
Tamm, 2004, Gage et al., 2005, Zhang et al., 2007).  
 
The trabecular meshwork and Schlemm’s canal are the last structures to differentiate during 
anterior segment development (Cvekl and Tamm, 2004). Both structures develop in the 
iridocorneal angle when a dense mass of mesenchyme cells elongates and separates. The 
resultant spaces between the cells become filled with extracellular fibers that are organised 
into lamella, thus forming a sieve-like trabecular meshwork (Kidson et al., 1999). This 
sieve-like arrangement is functionally important as it facilitates the outflow of aqueous 
humor. Scleral vessels next to the iridocorneal angle fuse to form the Schlemm’s canal 
which is in direct contact with the outer side of the trabecular meshwork (Cvekl and Tamm, 
2004). 
 
A set of mesenchyme cells with a stellate phenotype develop cell-cell contacts between the 
lamella of the trabecular meshwork and the endothelial lining of Schlemm’s canal. The 
trabecular network and Schlemm’s canal are directly responsible for aqueous humor 
outflow, thus these mesenchyme cells are particularly important as they provide the 
resistance that is required for aqueous humor outflow. By providing resistance to aqueous 
humor outflow, they play an important role in maintaining optimal IOP (Kidson et al., 




1.6 Postnatal development - morphological and proliferative changes 
associated with eyelid opening 
Eyelid development is initiated at E13.5 when the surface ectoderm adjacent to the 
developing cornea folds to form the lid buds (Figure 1.7). At this stage, the eyelids are 
simply surface ectoderm overlying undifferentiated mesenchyme.  
 
Figure 1.7: Eyelid development between E13.5 and E15.5. Presumptive corneal 
endothelium and stroma of neural crest derivation are shown in green. Developing eyelids 
are shown in blue. Image adapted from Besharse et al., 2010.  
 
Between E13.5 and E15.5, the eyelid buds continue to grow and extend over the ocular 
surface to form an outer epithelial layer that will become the epidermis and an inner 
epithelial layer that will become the conjunctiva (Kao et al., 2008, Gage and Zacharias, 
2009). The conjunctiva lines the inner surface of the eyelid. Mesenchyme cells, derived 
from migrating neural crest, differentiate into muscle cells, tarsal plate cells and other 
connective tissue within the eyelid.  
 
By E16, the epithelial cells along the edge of the upper and lower eyelid start to migrate 
over the developing cornea and subsequently fuse to form desmosomal junctions. Between 
E17 and early postnatal stages, appendix structures such as hair follicles, eyelid muscles, 
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cilia and lacrimal glands start to develop. Mouse eyelids are closed at birth and open at 
postnatal day 13 (P13) when the eyelid epithelial cells undergo apoptosis and necrosis at 
the fusion junctions causing the lids to open. By this stage, the corneal and conjunctival 
epithelia are completely matured, suggesting that closed eyelids at birth also serve as a 
protective barrier for the immature ocular tissues that are vulnerable to harmful 
environmental factors (Kao et al., 2008).  
 
Eyelid opening and epithelial stratification occur simultaneously. Eyelid opening exposes 
the eye to various environmental factors including changing oxygen levels, light and 
pathogens. It is therefore possible that the stratified epithelium serves as a protective barrier 
against fluctuating environmental factors, as well as fluid loss (Norman et al., 2004). Kao et 
al. (2008) hypothesised that closed eyelids at birth prevent the epithelium from 
keratinisation, thus maintaining corneal transparency. 
 
In the mouse, the epithelial cells undergo an exceptional level of differentiation that begins 
prior to eyelid opening. Between E10 and P13, the number of epithelial cell layers increases 
and the shape of the cells change from a flattened, ovoid phenotype to a more cuboidal 
phenotype following eyelid opening at P13. The epithelial cells proliferate to form 
intercellular junctions, which then become desmosomes. The mature cornea contains 3-4 
layers of desmosomes that prevent fluid loss and provide protection against pathogens 
(Zieske, 2004). Defects in eyelid closure cause an eye-open-at-birth (EOB) phenotype that 




1.7 Key regulatory genes and signaling molecules in corneal endothelial 
development 
Cellular migration and differentiation are directed by tissue specific expression of key 
regulatory genes and signaling molecules such as transcription factors, growth factors, 
nuclear proteins and enzymes, and other signal transduction molecules (Kao et al., 2008, 
Acharya et al., 2011). Transcription factors (TFs) are modular proteins that facilitate DNA 
binding, trans-activation or trans-repression (Carlsson and Mahlapuu, 2002). These 
regulatory genes and signaling molecules initiate a series of inductive events that direct 
morphogenesis of neural crest derived structures in the anterior segment of the eye (Ittner et 
al., 2005, Acharya et al., 2011).  
 
Based on literature to date, there is substantial evidence that POM cells migrate and 
differentiate into mature corneal endothelium under the influence of inductive signals from 
the lens and changes in key regulatory gene expression that direct this morphogenesis 
(Besharse et al., 2010). However, the precise molecular mechanisms of corneal endothelial 
differentiation are not completely understood (Langenberg et al., 2008).  
 
Transgenic and knockout models have been valuable tools in identifying and understanding 
the roles of genes and growth factors that are essential for corneal endothelial 
morphogenesis (Kao et al., 2008).  
 
1.7.1 The role of Foxc1 and Pitx2 in development 
TFs bind to DNA in a specific manner that plays a role in controlling mRNA synthesis of 
downstream targets. Foxc1, previously known as FKHL7 in humans or Mf1 (the murine 
homologue), is a member of the forkhead/winged helix family of TFs that are characterized 
by a conserved 110 amino acid DNA-binding domain known as the forkhead domain. 
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Foxc1 is widely expressed during embryogenesis and plays an important role in cell fate 
determination (Kume et al., 2000, Kume et al., 2001, Sommer et al., 2006). Foxc1 
expression is detected as early as E7.5 in neural crest cells and E12.5 POM cells in the 
developing eye (Kidson et al., 1999). 
 
Pitx2 is a member of the paired-bicoid family of homeodomain transcription factors that are 
involved in various developmental processes, notably anterior segment morphogenesis 
(Berry et al., 2006, Acharya et al., 2011). In the developing mouse eye, Pitx2 is expressed 
in POM cells, presumptive cornea and presumptive eyelids (Cvekl and Tamm, 2004). Both 
Foxc1 and Pitx2 are key regulatory TFs that direct differentiation of periocular 
mesenchyme into corneal endothelium (Besharse et al., 2010).  
 
Foxc1 and Pitx2 are involved in numerous developmental processes. Mutations in either 
result in a wide range of defects with different clinical phenotypes (Cvekl and Tamm, 
2004). Foxc1 null mutants are born with multiple developmental defects including 
hydrocephalus, abnormal kidney and ureter development, as well as abnormal 
cardiovascular development (Kume et al., 2000, Kume et al., 2001) . The anterior segment 
of the eye is severely defective in Foxc1 null mice. The cornea fails to separate from the 
lens and the corneal endothelium is unable to differentiate (Kidson et al., 1999). The 
precise role of Foxc1 in during the development of the eye is extensively reviewed by 
Nishimura et al., (2001).  
 
Pitx2 has been identified as a critical developmental gene as homozygous mutants die 
prenatally (Sowden, 2007). It is involved in the Nodal/Sonic hedgehog pathway that 
determines left/right axis formation during development (Hjalt et al., 2000). Numerous 
studies provide compelling evidence that Pitx2 plays an important role in anterior segment 
development (Hjalt et al., 2000, Hjalt et al., 2001, Berry et al., 2006, Strungaru et al., 
15 
 
2007). Pitx2 knockout mice display a range of abnormalities that include a drastic increase 
in corneal thickness and a disorganised corneal endothelium due to uncontrolled POM cell 
migration. These results suggest that Pitx2 controls the migration of presumptive corneal 
endothelium during murine corneal endothelial development (Gage et al., 1999). Pitx2 and 
Foxc1 mutations are directly associated with Axenfeld-Reiger syndrome (ARS) (Nishimura 
et al., 2001, Acharya et al., 2011).  
 
1.7.2 The role of the lens in corneal endothelial development 
Numerous studies have focused on identifying key organisers during eye development 
(Beebe and Coats, 2000, Thut et al., 2001, Zhang et al., 2007). Beebe and Coats (2000) 
investigated the role of the lens during avian eye development and found that complete 
ablation of the lens or replacement with a cellulose bead inhibited development of the 
corneal endothelium, corneal stroma, iris stroma and the anterior segment (Beebe and 
Coats, 2000). A study by Zhang et al. (2007) generated DREAM-Tox176 transgenic mice to 
show that corneal endothelial precursors are unable to undergo mesenchymal-to-epithelial 
transition to form mature corneal endothelium in the absence of the lens. Furthermore, lens 
ablation disrupted differentiation of the iris and interactions between the neuroectoderm 
and ocular mesenchyme. These results support the hypothesis that the lens is a key 
organiser during eye development (Zhang et al., 2007).  
 
The lens produces key signaling molecules that are required for the expression of TFs 
Foxc1 and Pitx2 during corneal development (Ittner et al., 2005). A recent study provides 
additional support for the role of the lens as a regulator of Foxc1 and Pitx2 expression 
during corneal endothelial development (Silla et al., 2014). Apart from transforming 
growth factor β-2 (TGFβ2), other signaling molecules that are produced and secreted by the 
lens have not been identified. 
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1.7.3 Key signaling molecules secreted by the lens during corneal 
endothelial development- transforming growth factors 
Transforming growth factors (TGFs) are a group of polypeptides that play important roles 
in cell differentiation and proliferation. TGFs are signaling molecules that are produced as a 
result of DNA binding to TFs (Besharse et al., 2010). TGF-β signaling is essential for 
normal corneal development as ligand inactivation or overexpression results in defective 
eye development (Saika et al., 2001, Flügel-Koch et al., 2002, Ittner et al., 2005). Tgf-β is 
expressed in the embryonic lens from E12.5 in wild type (WT) mice. Tgf-β2 null mice fail 
to develop a corneal endothelium as POM cells do not migrate over the developing lens 
(Saika et al., 2001, Besharse et al., 2010) and they exhibit a thin stromal layer compared to 
WT mice (Sanford et al., 1997).  
 
Although the importance of Foxc1 and Tgf-β expression in normal corneal development has 
been well established, few Foxc1 downstream targets have been identified. Transforming 
growth factor β-1 induced transcript 4 (Tgfβ1i4) has been identified as a downstream target 
of Foxc1, which provides a functional link between Foxc1 and Tgf-β and highlights their 
importance in eye development (Sommer et al., 2006).  
 
 1.8 Intercellular junctions in the corneal endothelium  
Intercellular junctions play a pivotal role in cell-cell adhesion and communication. They are 
especially important in cells such as corneal endothelial cells that require selective 
permeability between neighboring cells (Besharse et al., 2010). Intercellular junctions, 
namely gap, adherens and tight junctions, facilitate cell adhesion between adjacent cells, 
thus allowing the formation of a monolayer that is characteristic of corneal endothelial cells 
(Zhu et al., 2008). The mature corneal endothelium expresses both adherens and tight 




Cellular communication is regulated by the transport of molecules through the trans-
cellular pathway (via the cytoplasm) and the para-cellular pathway (via spaces between 
cells). Tight junctions are essentially the cell-cell junctions that divide plasma membranes 
into apical and basolateral compartments and regulate the permeability of the para-cellular 
pathway (Ryeom et al., 2000, Ban et al., 2003).  
 
The functions of tight junctions can therefore be described as the ‘fence’ function, ‘barrier’ 
function and signaling function (Kojima et al., 2009). Tight junctions have a ‘barrier’ 
function as they are semipermeable and therefore inhibit the movement of solutes and water 
between paracellular spaces. By separating cells in apical and basolateral compartments, 
tight junctions create cell polarity and therefore exhibit a ‘fence’ function. The ‘signaling’ 
function of tight junction proteins was reviewed by Kojima et al., (2009) in hepatocytes 
(Figure 1.8). 
  
Figure 1.8: The functions of tight junctions termed ‘fence’; ‘barrier’ and ‘signaling’. Image 
adapted from Kojima et al. (2009).  
The primary function of tight junctions is to regulate solute, ion and fluid transport between 
adjacent cells. Tight junctions consist of two main transmembrane proteins: claudins and 
occludins. Both claudins and occludins have extracellular domains that extend across the 
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plasma membranes of adjacent cells, thus forming a branching network that seals the spaces 
between cells. They connect to the actin cytoskeleton in the cell through a network of 
proteins known as zonula occludins (Zo) (Figure 1.9 A) (Niessen, 2007). 
 
1.8.1 The role of Zo1 in corneal endothelial development and physiology 
Zonula occludin-1 (Zo1) is a selectively semipermeable tight junction protein that belongs 
to the membrane-associated guanylate kinase (MAGuK) family of proteins (Ryeom et al., 
2000). Protein members of the MAGuk family have a cassette of protein binding domains 
that include one or more PSD95/dgl/Zo-1 (PDZ) domains, a SH3 domain and a region 
homologous to guanylate kinase (GuK) (Figure 1.9 B). These domains serve as receptor, 
signaling and transport complexes within the plasma membrane. Zo1 proteins bind to 
claudins and occludins, as well as other cytoskeletal proteins such as vinculin and cingulin 
(Figure 1.9 A). These proteins collectively form the structural components of the tight 
junctions that bridge the paracellular spaces between adjacent cells (Stevenson et al., 1986, 
Sugrue and Zieske, 1997, Ban et al., 2003, Kojima et al., 2009). Claudin and occludin are 
integral membrane proteins that limit intercellular spaces, thereby forming channels that 
regulate the movement of ions between adjacent cells (Ryeom et al., 2000). Zo1 is 
therefore the scaffold to which other integral membrane proteins bind. Zo1 expression is 
therefore required for other tight junction proteins such as claudins and occludins to 
connect to the cytoskeleton of the cell (Figure 1.9 A).  
 
The junction adhesion molecule (JAM) is a transmembrane protein that is associated with 
the formation of tight junctions. JAM proteins, however, are not directly involved in 
forming the claudin and occludin branching network. Although their exact function is 
unknown, JAM proteins are thought to be involved in strengthening the tight junctions 




     
Figure 1.9: The formation of tight junctions (A). Imaged adapted from 
https://www.google.co.za/search?q=tight+junctions+physiology.org. Zo1 binding domains 
(B). Image adapted from Kojima et al., 2009. 
 
Given the dual role of Zo1 as a ‘barrier’ and a signal transducer, studies have suggested 
various functions for the domains of Zo1 proteins. The domains are required for structural 
organisation and each domain is thought to be responsible for various signal transduction 
pathways (Ryeom et al., 2000, Bauer et al., 2010). Zo1 has a cassette of protein binding 
domains that includes a PSD95/dgl/Zo-1 (PDZ) domain, a SH3 domain and a region 
homologous to guanylate kinase (GuK). Bauer et al. (2010) reported that the PDZ domain 
plays a role in cell signaling and the SH3 domain is involved in signaling pathways that 
regulate the cytoskeleton. These functions play a role in determining the protein 
localisation of Zo1. Ryeom et al. (2000) analysed exogenous Zo1 expression using stable 
mutant corneal epithelial cell lines that were generated to exclude each domain. They then 
assessed Zo1 cellular localisation in each mutant cell line and found that the C-terminal 
mutant was localised to cell borders, and the N-terminal mutant was localised in the 





Zo1 is expressed very early in embryonic development and has been shown to be required 
for morula to blastocyst transformation in the mouse (Wang et al., 2008). Zo1 is a 
predominant function related protein whose expression has been used as a marker of mature 
corneal endothelium in rat (Ju et al., 2012), human (Zhu et al., 2008, Fan et al., 2011) and 
mouse corneal tissue (Cao et al., 2002). Corneal endothelial tight junctions are expressed as 
a discontinuous band which allows aqueous humor to flow into the stroma through the gaps 
between the cells. 
 
Adherens junctions are mediated by cadherins and catenins, such as N-cadherin (N-cad) 
and β-catenin respectively. Notably, N-cad is also an important marker of function in 
corneal endothelial cells (Zhu et al., 2008). 
 
1.9 Water transport proteins – Aquaporin 1 
Aquaporins (AQPs) are a family of membrane spanning proteins that have diverse 
physiological functions as key mediators of transcellular fluid transport. Research spanning 
decades has led to the identification of 13 mammalian AQP homologues (Agre et al., 1993, 
Montiel et al., 2014) that are expressed in endothelial and epithelial tissues, as well as other 
tissues that are involved in fluid transport such as kidney tubules (Thiagarajah and 
Verkman, 2002). AQPs can be clustered into two subsets: classical aquaporins (as they 
were initially considered to be exclusive water pores) and aquaglyceroporins (as they are 
permeable to water and glycerol) (Agre et al., 1993). Functional studies show that Aqp1, 
Aqp2, Aqp4, Aqp5 and Aqp8 are water selective and are therefore classical AQPs, and 
Aqp3, Aqp7 and Aqp9 also transport glycerol and other small solutes and are therefore 




Aqp1 was the first to be discovered by Agre and colleagues in 1991. It is constitutively 
organised as a homotetramer. Each monomeric subunit contains 269 amino acid residues 
that form two tandem repeats of three membrane spanning alpha-helices, each forming 6 
transmembrane domains connected by 5 loops (A-E). As a result of the repeated Asu-Pro-
Ala consensus motif, the cytoplasmic loop B and extracellular loop E domains dip into the 
membrane, thus contributing to the central constriction site within the pore. The second 
arginine outer constriction group confers selectivity in solute permeation. Structural studies 
have demonstrated that each monomer functions as an independent water pore but overall 
the tetrameric organisation is required for correct functioning of the protein (Hendriks et 
al., 2004, Montiel et al., 2014). 
 
The plasma membrane is essentially a lipid bilayer that is permeable to water, in addition to 
a set of proteins that form water channels such as AQPs. There is a distinct difference 
between diffusional and channel-mediated water transport. Diffusion is a low capacity, 
bidirectional movement of water that occurs across all cell membranes, whereas channel-
mediated permeability has a higher capacity for water transport. AQP channel-mediated 
permeability is selective as water crosses the channel without resistance while hydrophobic 
ions, for example, cannot permeate the channel. AQPs therefore function as water selective 
plasma membrane transporters that facilitate the bidirectional movement of water between 
the endothelium and the stroma in response to osmotic gradients and hydrostatic pressure 
(Thiagarajah and Verkman, 2002, Macnamara et al., 2004). Since the movement of water is 
directed by osmotic gradients, AQPs are not pumps or exchangers, but simply form a 
channel that allows water to move through the membrane (Agre et al., 1993, Agre, 2004). 
As previously discussed, the corneal endothelium maintains deturgescence by transporting 
water and other solutes between the stroma and the aqueous humor in the anterior chamber. 
Corneal transparency requires constant regulation of solute content and water. The stroma 
is hyperosmolar relative to the aqueous fluid due to the high concentration of negatively 
charged glycosaminoglycans and consequent accumulation of cations, thus causing stromal 
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swelling (Thiagarajah and Verkman, 2002, Macnamara et al., 2004). Therefore, active 
solute transport out of the stroma, across the endothelium and into the anterior chamber is 
critical for transparency to counteract the tendency of the stroma to absorb water. The 
endothelium utilises transport proteins such as sodium potassium ATPase (Na+ K+ ATPase) 
and sodium potassium chloride (Na/KCl) that pump solutes, primarily sodium and 
bicarbonate, from the stroma into the aqueous chamber (Thiagarajah and Verkman, 2002, 
Besharse et al., 2010). These salt pumps create an osmotic gradient that allows excess 
water to passively move from the stroma across the endothelium into the anterior chamber 
through AQP water channels (Thiagarajah and Verkman, 2002, Macnamara et al., 2004). 
Corneal transparency requires approximately 78% water by weight (Thiagarajah and 
Verkman, 2002, Macnamara et al., 2004), thus excess water entering the cornea must be 
extruded through AQP water channels to maintain a natural hyperosmotic state (Zhang et 
al., 2002) and overall corneal deturgescence (Besharse et al., 2010). 
 
Hydrostatic pressure, defined as IOP, is an important index of eye physiology (Zhang et al., 
2002). Regulated IOP depends on the rate of aqueous fluid production by the ciliary 
epithelium and the rate of aqueous fluid outflow from Schlemm’s canal into the venous 
system (Zhang et al., 2002). Aqueous fluid production involves passive water transport 
which is driven by active salt transport across the ciliary epithelium, whereas aqueous fluid 
outflow involves pressure driven bulk outflow from Schlemm’s canal (Zhang et al., 2002). 
Such water transport is facilitated by AQP water channels (Zhang et al., 2002). Therefore, 
AQPs are involved in regulating IOP by facilitating aqueous fluid production and outflow 
(Zhang et al., 2002).  
Tissue distribution has provided indirect roles for AQPs in various physiological processes.  
The eye expresses several AQPs at important sites of fluid transport (Figure 1.10) 




Figure 1.10: Sites of aquaporin expression in the eye. Image adapted from Verkman 2009.  
 
Tissues that express Aqp1 and Aqp4 are involved in IOP regulation and Aqp0, Aqp1 and 
Aqp5 are responsible for lens and corneal transparency. Aqp4 is expressed in tissue 
responsible for visual signal transduction and Aqp3 is involved in tear film homeostasis and 
conjunctival barrier function. Aqp5 is involved in tear formation by the lacrimal glands 
(Verkman, 2009).  
 
Knockout (KO) models have provided compelling evidence for the roles of AQPs in 




Table 1.1: Tissue specific roles of aquaporin homologues and their associated experimental 
phenotype. 




Additional notes Reference 
Aqp1 Sites of fluid production 
(ciliary epithelium) and 
outflow (trabecular 
meshwork) in the cornea. 
It is expressed in the lens 
epithelium and corneal 
endothelium. Plays a role 
in corneal and lens 
transparency 
 
Aqp1 null mice have reduced 
corneal thickness (WT 123µm 
in WT mice compared to 
101µm in Aqp1 null mice) 
 
Delayed recovery of corneal 
transparency and thickness after 
exposure to hypotonic saline 
solution (75% recovery at 7 
minutes in WT mice compared 
to 5% recovery in Aqp1 null 
mice) 
 
KO mice show a small yet 
significant reduction in IOP 
with reduced aqueous fluid 
secretion  
 
Lenses from Aqp1 null mice 
have reduced osmotic 
permeability across the lens 
epithelium. Also, significantly 
greater water content of the lens  
  
Aqp1 Null mice: in vitro, 
accelerated loss of lens 
transparency following 
incubation in high glucose 







Baseline transparency did 
not change by Aqp1 
deletion. Hypothesized 
that Aqp1 upregulation 
may reduce corneal 
swelling after injury 
 
 







transparency was not 
altered by Aqp1 KO 
 
 
Data suggest that Aqp1 
facilitates lens 


































The data reviewed in table 1.10 collectively provide functional evidence for the roles of 
AQPs in eye physiology, particularly the role of Aqp1 in fluid extrusion from the stroma 
across the endothelium.   
 
The entire cornea is nourished by proteins and other essential substances found in the 
aqueous humor. These nutrients are transported across the endothelium and into the rest of 
the cornea by the endothelial pump function. Knockout models and techniques such as 
siRNA knockdown have facilitated new ways of testing and understanding the molecular 
mechanisms underlying the corneal endothelial pump function. Aqp1 knockout models 
have encouraged researchers to re-evaluate the mechanisms underlying solute-fluid 
coupling and the corneal endothelial pump (Bonanno, 2012). 
  




Additional notes Reference 
Aqp3 Conjunctival epithelium, 
plays a role in the 
epithelial barrier function 
and water permeability 
Aqp3 KO mice have a slower 
water permeability in 
conjunctiva  
A mathematical model of 
tear film osmolarity  was 
developed, providing 
insights into the 
pathophysiology of dry 




Aqp5 Corneal epithelium and 
lacrimal gland  
Aqp5 deletion in mice showed 
reduced corneal swelling after 
exposure to hypotonic saline 
solution 
 
Aqp5 null mice have increased 
corneal thickness (WT 123µm 
in WT mice compared to 











1.10 The role of solute carriers in the pump function of the corneal 
endothelium. 
Bicarbonate ions (HCO3-) play an important role in the pump function of the corneal 
endothelium that is required to maintain deturgescence (Suzuki et al., 2012). Proteins 
belonging to the solute carrier 4 (Slc4) family transport cellular HCO3- across plasma 
membranes (Bonanno, 2012, Shei et al., 2013). The Slc4 family consists of 3 functionally 
distinct groups: electroneutral sodium-independent chloride bicarbonate exchangers (Cl-
/HCO3-), electroneutral sodium-bicarbonate (Na+:HCO3-) cotransporters and sodium driven 
exchangers. Slc4a4, which encodes the sodium bicarbonate cotransporter NBCe1 gene, is a 
Na+:HCO3- cotransporter that is localized to the basolateral membrane of corneal 
endothelial cells (Shei et al., 2013).  
 
Aqueous humor secretion that is coupled to ion changes depends on active transport 
mechanisms to create osmotic gradients that direct the movement of water across the 
endothelium (Bonanno, 2012). Ion pumps create an osmotic gradient that allows water to 
passively move from the stroma across the endothelium into the anterior chamber. As 
discussed previously, the hyperosmolar stroma absorbs water by osmosis (Thiagarajah and 
Verkman, 2002, Macnamara et al., 2004). Therefore, active solute transport across the 
endothelium is critical for deturgescence to counteract the tendency of the stroma to absorb 
water.  
 
The pump function is energy driven and requires Na+K+ATPase and carbonic anhydrase, 
which is an enzyme that converts carbon dioxide and water to bicarbonate ions. These 
bicarbonate ions are translocated across plasma membranes and allow water to passively 
flow through. Studies show that carbonic anhydrase inhibitors prevent the process of fluid 





Figure 1.11: Molecular mechanisms underlying the corneal endothelial pump function - 
Bicarbonate transport model for the corneal endothelium. Image adapted from Bonanno 
2012.  
 
Bonanno (2012) proposed a possible bicarbonate transport model for the corneal 
endothelium (Figure 1.11). Fluid coupled anion secretion requires transendothelial transport 
of Cl- and HCO3- (Figure 1.11 A). Na+K+ATPase, present in the basolateral membrane, 
creates a low intracellular concentration of Na+ ions (Figure 1.11 B) and a high intracellular 
concentration of K+ ions (Figure 1.11 C). The net negative charge creates a small potential 
difference that attracts Na+ through the paracellular pathway across tight junctions. The net 
movement of Na+ and HCO3- creates an osmotic driving force that facilitates the movement 
of water along the osmotic gradient. The basolateral membrane also contains the 
electrogenic sodium bicarbonate cotransporter (1Na+/2HCO3-), the chloride bicarbonate 
exchanger (Cl-/HCO3-) and the sodium hydrogen exchanger (Na+/ H+). The sodium 
bicarbonate cotransporter Slc4a4 directly deposits HCO3- into the cell (Figure 1.11 D). The 
Na+/ H+ exchanger (Figure 1.11 E) can deposit HCO3- into the cell indirectly because the 
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removal of protons favors formation of HCO3- from carbon dioxide, which is catalyzed by 
carbonic anhydrase II (Figure 1.11 F). The Cl-/HCO3- exchanger removes HCO3- from the 
cell and adds intracellular Cl- (Figure 1.11 G). This model suggests that HCO3- is taken up 
on the basolateral side and HCO3- outflow occurs across the apical side through anion 
channels (Bonanno, 2012). 
 
Immunohistochemistry studies indicate that Slc4a4 is exclusively expressed in the 
basolateral membrane of rat, bovine and human corneal endothelium. NBCe1 siRNA 
knockdown experiments in cultured bovine corneal endothelium show significantly reduced 
basolateral HCO3- permeability and reduced basolateral to apical HCO3- transport. Notably, 
apical HCO3- to basolateral transport was not affected by siRNA knockdown, indicating 
that functional Slc4a4 is only present in the basolateral membrane and that it is required for 
majority of basolateral HCO3- inflow (Bonanno, 2012). 
 
Several members of the Slc4 family have been implicated in the development of ocular and 
corneal diseases such as cataracts, band keratopathy and glaucoma. Band keratopathy is a 
form of corneal degeneration that is characterized by the appearance of bands around the 
cornea formed by elevated levels calcium deposition.  NBCe1 mutations increase the 
concentration of intracellular HCO3- which causes an increase in calcium deposition that 





Figure 1.12: Proposed method of band keratopathy caused by NBCe1 mutations (encoded 
by Slc4a4) (A). Image adapted from Suzuki et al., 2010. Calcific band keratopathy (B). 
Image adapted from https://www.google.co.za/search?q=calcific+band+keratopathy.  
 
Developmental eye disorders affect millions worldwide. Axen-Reiger Syndrome (ARS) and 
Peters Anomaly of two of the most cited developmental eye disorders that occur as a result 
of disrupted morphogenesis in the anterior segment of the eye. Corneal endothelial 
dystrophies such as Bullous Keratoplasty and Fuch’s endothelial dystrophy are the two 
leading causes of corneal transplant surgery in the United States. Despite the high success 
rates of corneal transplant surgery, donor graft tissue is a limited resource (Alward, 2000, 
Reneker et al., 2000, Nishimura et al., 2001). There is therefore an urgent need for 
innovative regenerative techniques to further our understanding of corneal endothelial 
dysfunction and to produce viable bio-engineered corneal tissue. 
 
1.11 Research aims and objectives  
The principle function of the corneal endothelium is to regulate and maintain optimal 
stromal hydration, consequently preserving corneal transparency. Simple diffusion cannot 




transporters, channels and tight junctions facilitate fluid production, absorption and 
secretion of nutrients and metabolites throughout the cornea (Ruiz-Ederra and Verkman, 
2006).  
 
This study aims to establish an in vitro model of murine corneal endothelial development in 
order to elucidate the molecular events that result in proper differentiation of the corneal 
endothelium. This will be achieved by developing an in vitro model of corneal endothelial 
development and assessing the expression patterns of key function related genes and 
proteins. This information will contribute to the body of knowledge that exists and perhaps 
be used to direct the differentiation of induced pluripotent stem cells towards a corneal 
endothelial phenotype.  
 
Aim 1: To recapitulate the development of the corneal endothelium by determining the 
endogenous gene and protein expression patterns of key functional genes associated with 
initiation of differentiation, the differentiated state and the fully functioning endothelium.  
 
Objectives: 
a) To generate presumptive corneal endothelial cell lines from 1: E14.5 and E15.5 
embryos and 2. From post natal stage P13 when the eyelids open and the corneal 
endothelium is functional. Cell lines from earlier developmental stages (E12.5 and 
E13.5) have already been generated by other members of the laboratory.   
 
b) To determine the gene expression patterns of Zo1, Aqp1 and Slc4a4 (markers of 
differentiated and functional corneal endothelium) at E12.5, E13.5, E14.5, E15.5 
and P13  
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c) To determine the protein expression patterns of Zo1 and Aqp1 at the 
aforementioned developmental stages. 
Preliminary data shows that E12.5 and E13.5 cells are able to form adherens junctions 
characterised by the presence of N-cadherin in the cell membranes. Therefore, confocal 
microscopy will be used to: 
d) Assess the ability of the cell lines to form tight junctions using Zo-1 antibodies.   
e) Determine the presence of Aqp1 proteins to assess the functional capability of the 
cells.  
 
Figure 1.13: Schematic representation of the research aims. Zo1 is a tight junction protein, 
expressed corneal endothelial cell membranes, that facilitates the formation of the resilient 
monolayer that is characteristic of the corneal endothelium. Aqp1 is a bidirectional water 
channel protein that mediates transcellular fluid transport across the corneal endothelium, 
while Slc4a4 is an ion pump that transports cellular bicarbonate ions across plasma 








expression patterns of these functional genes in an in vitro model of corneal endothelial 
development.  
 
Aim 2: To establish a stable Foxc1 knockdown cell line.  
Objectives:  
a) To sub-clone a hairpin siRNA insert targeting murine Foxc1 expression into a 
commercial vector for stable knockdown.  
b) To transfect corneal endothelial cells with the siRNA expression vector and assess 
the effects of Foxc1 knockdown on the gene expression levels of the functional 
genes assessed in this study.  
 
It must be noted that, despite numerous attempts to sub-clone the siRNA insert into the 
expression vector, this was not achieved within the time frame of this research project. 
However, since an immense amount of work and trouble-shooting was performed, details 




2. MATERIALS AND METHODS 
2.1 Animal handling 
The use of the BALB/c mice in this study was approved by the University of KwaZulu-
Natal (UKZN) Animal Research Ethics Committee (ethics number 022/15/ANIMAL). The 
animals were obtained from the Bio-Medical research Unit (BMRU) at UKZN. Animal 
handling was done in accordance with the UKZN animal experimentation regulations. The 
mice were fed a constant diet of dry pellets and water in accordance with the UKZN ethical 
rules and regulations. Human Endpoint observation forms were completed daily to ensure 
the well-being of the animals as requested by the National Council of societies for the 
Prevention of Cruelty to Animals (NSCPA). 
 
2.1.1 Timed matings 
In order to establish an in vitro model of murine corneal endothelial development, timed 
matings were performed to obtain embryos and mouse pups for dissections at the relevant 
stages of development (E14.5, E15.5 and P13). Noon on the day of the vaginal plug was 
considered E0.5 (http://www.acuc.berkeley.edu/guidelines.html).  
 
2.2 Derivation of primary cultures 
Primary cultures of presumptive corneal endothelial cells were derived from wild-type 
mouse embryos at embryonic day (E) 14.5 and E15.5, and mature corneal endothelial cells 
were derived from wild-type mouse pups at post-natal day (P) 13 developmental stages. All 
dissections were performed using a Stemi DV4 stereo microscope (Zeiss, Germany) and 
tungsten dissecting needles sharpened using electro-chemical etching in KOH solution at 
150 V (Appendix 4.1a). All surfaces and dissecting equipment were sterilized with 70% 
ethanol (Appendix 4.1b). Dissecting needles were sterilized with UV irradiation prior to use 
and rinsed in 1x phosphate buffer saline (PBS) (Appendix 4.1c), 70% ethanol and heat 
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sterilized in a glass bead sterilizer (Simon Keller, Switzerland). The dissecting needles were 
sterilized between uses on each embryo to prevent cross contamination. 
 
Pregnant females and P13 mouse pups were initially euthanized by Halothane exposure and 
later by exposure to carbon dioxide as per UKZN BRU guidelines. Embryos were harvested 
by caesarian section. Each embryo or pup was placed in a petri dish on ice containing 1x 





























  Position of iris and lens 
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Figure 2.1: The stepwise procedure for the derivation of periocular mesenchyme cells from 
the eyes of mouse embryos.  Black denotes the tissue of the eye, dark blue the position of 
the iris and lens within the eye and light blue the remainder of the embryo (image obtained 
from Jerolen Naidoo, MSc thesis 2011). 
(1) The head of the embryo or pup was carefully dissected away from the body. (2) The 
head was bisected longitudinally with each half containing one eye. (3) Each eye was then 
carefully excised from the head using the fine dissecting needles. Careful attention ensured 
that the eye was not punctured by the needles and all extra ocular head tissue was removed. 
(4) Each eye was bisected laterally to separate the anterior and posterior sections of the eye. 
(5) Small wedges were dissected from the anterior regions of the eyes. A mouth pipette was 
used to transfer the small wedges to the well of a 24 well plate containing 500µl 
Dulbecco’s Modified Essential Eagle’s Medium (DMEM) (Invitrogen, USA) supplemented 
with 20% inactivated foetal bovine serum (FBS) (Invitrogen, USA) and 0.5ug/mL 
penicillin/streptomycin (pen/strep) (Lonza, Germany). Four to five wedges from a single 
eye were cultured in a single well of a 24 well plate. Primary cultures were allowed to 
expand for 72 hours and migrate away from the explants before subsequent immortalisation 
(Figure 2.1). 
 
2.3 Immortalisation of primary cultures 
Primary cultures of POM cells were immortalised by infection with a temperature sensitive 
SV40 large T-antigen with Geneticin (G418) (Sigma-Aldrich®, USA) resistance as 
described by Sommer et al. (2006). The RV 200 Viraductin™ Retrovirus Transduction kit 
(Cell Biolabs Inc., USA) was used to facilitate immortalisation of primary presumptive 
corneal endothelial cells at E14.5 and E15.5 and mature corneal endothelial cells at P13. 
The virus was obtained from the conditioned medium of Ψ2 producer cells that were 
cultured at 37°C in DMEM (Invitrogen, USA) containing 10% FBS (Invitrogen, USA) and 
0.5 µg/mL pen/strep (Invitrogen, USA). Conditioned medium was harvested from Ψ2 





2000 rpm for 1 minute to remove all cellular debris and filter sterilised using a 0.2 micron 
filter and a sterile syringe.  
For a single well in a 24-well plate containing primary cultures, 5 µl of 100x Reagent A 
(Cell Biolabs Inc., USA) were added to 490 µl of Ψ2 conditioned medium in a sterile 
micro-centrifuge tube. The mixture was gently inverted several times to mix the solution 
and 5 µl of Reagent B (Cell Biolabs., USA) was added. The solution containing Reagent A, 
Ψ2 conditioned medium and Reagent B was gently inverted several times and incubated at 
37°C for 30 minutes. The mixture was then centrifuged at 12 000 x g for 10 minutes at 4°C. 
Following centrifugation, the supernatant was discarded and the pellet was resuspended in 
500 µl of fresh antibiotic-free culture medium by vortexing. Culture medium in each well 
was aspirated and replaced with the mixture containing the pellet of cells. The 24-well plate 
was then incubated at 37°C overnight. The following day, the mixture was aspirated from 
each well and replaced with 500 µl of a solution containing Reagent C (Cell Biolabs., USA) 
and normal culture medium in a 1:8 ratio respectively. The 24-well plate was gently swirled 
for approximately one minute. The solution containing Reagent C was then aspirated and 
the cells were rinsed twice with 300 µl of culture medium containing 20% FBS. 500 µl of 
culture medium was added to each well. The cells were then cultured at 37°C for 48-72 
hours before G418 antibiotic selection began. G418 antibiotic pressure was applied to 
select successfully infected cells. G418 was added to the culture medium at a concentration 
of 400 µg/mL and applied to each well. Antibiotic selection continued for 10-14 days to 
ensure the selection of immortalised cells. Mouse embryonic fibroblasts dissected from the 
head region of the embryos and pups were not immortalised and used as controls for 
antibiotic selection. These untransformed fibroblasts did not survive the antibiotic selection 
process. Immortalised presumptive and mature corneal endothelial cells were cultured in 
DMEM containing 20% FBS and 0.5 µg/mL pen/strep for approximately 2 weeks, after 





2.4 Cell culture 
Tissue culture was carried out in a class two, type A2 categorised laminar flow (Logic 
labconco®). Cells were incubated at 37°C in a humidified Shel Lab 3553 CO2 incubator 
(United Scientific (Pty) Ltd) supplemented with 5% CO2. Stock cultures of each cell line 
were maintained in 75 cm3 tissue culture  (T75) flasks (Corning, USA) containing 10 mL 
DMEM culture medium supplemented with 10% FBS (Invitrogen, USA) and 0.5µg/mL 
pen/strep (Invitrogen, USA). Working stocks were maintained in 10 cm3 dishes (Corning, 
USA) containing 10 mL DMEM culture medium supplemented with 10% FBS (Invitrogen, 
USA) and 0.5µg/mL pen/strep (Invitrogen, USA). Cell growth was examined using an 
inverted Nikon TMS-F microscope (Nikon, Japan). Confluent cells were passaged by 
adding 1 mL of 1x Trypsin-EDTA (PAA) (Appendix 4.1d) to a T75 flask. The flask 
containing the trypsin-EDTA solution was then incubated at 37°C until the cells detached 
from the bottom of the flask. 2 mL culture medium was added to the flask to neutralize the 
trypsin-EDTA solution. Immortalised POM cultures at E12.5 and E13.5 were created by 
other members of the laboratory and were maintained in 10 cm3 dishes (Corning, USA) 
containing 10 mL DMEM culture medium supplemented with 10% FBS and 0.5µg/mL 
pen/strep (Invitrogen, USA). 
  
All the experiments were performed on passage 6≤p≥11 POM cells at E12.5 and E13.5, and 
passage 4≤p≥9 presumptive corneal endothelial cells at E14.5 and E15.5, and mature 
corneal endothelial cells at P13. 
 
Each cell line was regularly tested for Mycoplasma infection using a Hoechst nuclear stain 
(Appendix 4.1e). Stained slides were viewed using a fluorescent microscope. All the cell 
lines were negative for Mycoplasma infection. 
 
2.5 RNA extraction 
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RNA was extracted from cells using a QIAGEN RNeasy Kit according to the 
manufacturer’s instructions for purification of total RNA using spin technology.  
Culture medium from selected culture dishes was aspirated and discarded. Expression of 
adherens and tight junction mRNA transcripts is disrupted by trypsin-EDTA treatment (Zhu 
et al., 2008), therefore adherent corneal endothelial cells were harvested using a cell scraper 
(Biologix Research Company) and collected in a sterile 15 mL centrifuge tube. The culture 
dishes were rinsed with 1x PBS which was collected in the same centrifuge tube. The 
centrifuge tube was then centrifuged at 1000 x g for 5 minutes at room temperature. The 
supernatant was discarded and the pellet of cells was re-suspended in 600 µl RLT lysis 
buffer. The cells were homogenised by pipetting and briefly vortexed for 10 seconds.  The 
cell lysate was pipetted into a QIAshredder (QIAGEN) which was centrifuged at 10 000 
rpm for 2 minutes at room temperature. The QIAshredder column was discarded and 600 µl 
of 70% ethanol was added to the 2 mL collection tube containing the cell lysate. The 
solution containing the cell lysate and 70% ethanol was mixed by pipetting and added to an 
RNeasy spin column placed in a 2mL collection tube. The RNeasy spin column was 
centrifuged at 10 000 rpm for 15 seconds at room temperature. The flow-through was 
discarded and 700 µl of RW1 buffer was added to the RNeasy spin column which was then 
centrifuged at 10 000 rpm for 15 seconds at room temperature. The flow-through was 
discarded and 500 µl of RPE buffer was then added to the RNeasy spin column and 
centrifuged at 10 000 rpm for 15 seconds at room temperature. The flow-through was 
discarded and the RNeasy spin column was placed in a new 2 mL collection tube. The 
RNeasy spin column was centrifuged at 10 000 rpm for 1 minute to remove all traces of 
RPE buffer on the membrane. The RNeasy spin column was placed in a 1.5 mL micro-
centrifuge tube and 30 µl of nuclease free water was pipetted directly onto the membrane to 
elute the RNA. The micro-centrifuge tube containing the RNeasy spin column was 
incubated at room temperature for 5 minutes, after which it was centrifuged at 10 000 rpm 




2.5.1 RNA quantification 
Total RNA samples were quantified using a Spectrophotometer ND1000 (NanoDrop 
technologies) using ND V3.5.2 software in accordance with the MIQE guidelines (Bustin et 
al., 2009). Readings at A260 indicated the RNA concentration and the A260/280 ratio indicated 
the RNA purity (pure RNA has an A260/280   ratio between 1.8 and 2.1). RNA samples were 
aliquoted in volumes equivalent to 2 µg of RNA to ensure that each sample was only 
subjected to one freeze-thaw cycle. RNA samples were stored at -80°C immediately after 
quantification. 
  
2.5.2 Validation of RNA integrity 
RNA integrity was evaluated by gel electrophoresis. RNA samples were separated on a 1% 
bleach agarose gel (Appendix 4.1f) containing 5 µg/mL ethidium bromide.  The gels were 
run in 1x Tris-base-acetate buffer (TAE) running buffer (Appendix 3.1g) by electrophoresis 
at 100 V for 35 minutes. An O’GeneRuler™ DNA molecular weight marker (MW) (range 
100-10 000 bp, Thermo Scientific, USA) was loaded into the first lane of every gel for 
reference. 2 µl 6X loading dye (Thermo Scientific, USA) was added to the equivalent 
volume of 1 µg of total RNA which was then loaded into a single well in the gel. Gels were 
visualised and bands were detected under UV light in a Bio-Rad Chemidoc® XRS+ 
imaging system (Bio-rad, USA). Image Lab™ software version 2.0.1 (Bio-rad, USA) was 
used to analyse detected bands.  
 
The integrity of the RNA samples was confirmed by the presence of two bands of the 28S 
and 18S ribosomal subunit RNA (Figure 3.2). As shown in Figure 3.2, the RNA samples 




2.6 cDNA Synthesis 
The GoScript™ Reverse Transcription System (Promega, USA) was used to synthesise 
complimentary DNA (cDNA). The kit includes a reverse transcriptase and specialised 
reagents for efficient synthesis of first-strand cDNA optimised for quantitative PCR 
analysis. A standard concentration of 2 µg RNA was used for cDNA synthesis in a Bio-Rad 
My cycler™ thermal cycler.  
 
2.6.1 Poly (A) Tailing 
RNA samples were thawed on ice prior to cDNA synthesis. For a single reaction, 2 µg 
RNA and 1 µl 50 µM Oligo(dT)15 Primer were added to a sterile PCR tube. Nuclease free 
water was then added to the reaction to make up a final volume of 10 µl. This solution was 
incubated for 5 minutes at 70°C, after which it was briefly centrifuged and incubated on ice 
for additional 5 minutes.  
 
2.6.2 First strand cDNA synthesis 
A mastermix containing 4 µl GoScript™ 5x reaction buffer, 2.5 µl 25mM MgCl2, 1 µl of 
GoScript™ random primers (dNTPs), 1 µl Recombinant RNasin® Ribonuclease Inhibitor 
and 5.5 µl nuclease free water (per reaction) was prepared and added to the RNA solution 
after the 5 minute incubation period on ice. 14 µl of the mastermix solution was added into 
each sample. The solution was briefly centrifuged and 1 µl GoScript™ Reverse 
Transcriptase (RT) was added directly into each sample. The solution was briefly 
centrifuged and incubated in a Bio-Rad My cycler™ thermal cycler at 25°C for 5 minutes; 
42°C for 60 minutes and 70°C for 15 minutes. 
 
A no-reverse transcriptase (no-RT) control and a no-template control (NTC) control 
(negative controls) was prepared for each RNA sample in which the reverse transcriptase 
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and template/RNA respectively was replaced by nuclease free water. Fresh cDNA was 
aliquoted immediately and stored at -80°C. All cDNA samples were synthesised using the 
same kit to ensure an accurate and comparable representation of subsequent data. 
 
2.7 Conventional PCR 
Conventional PCR was used to determine the efficacy of the following primer sets (Table 
2.1) and the presence of each gene in POM cells at E12.5 and E13.5, presumptive corneal 
endothelial cells at E14.5, E15.5 and mature corneal endothelium at P13.  
 
Table 2.1: Primer sequences of the genes of interest and reference genes used in this study.  
Gene Orientation Sequence (5’-3’) Product size (bp) Source 
Zo1 Forward GGCTTAGAGGAAGGTGATCAAA 100 Shei et al., 2013 
 Reverse CTTTAGGGAGGTCAAGGAGGA   
Aqp1 Forward CTACACTGGCTGCGGTATCA 143 Shei et al., 2013 
 Reverse GGGCCAGGATGAAGTCATAG   
Slc4a4 Forward TCCCTTCATTGCCTTTGTTC 151 Shei et al., 2013 
 Reverse CAAGGTGGCGATAGCTCTTC   
Hprt Forward GTCCCAGCGTCGTGATTAGCGAT 206 Sommer et al., 2006 
 Reverse GGGCCACAATGTGATGGCCTCC   
β-actin Forward CTAAGGCCAACCGTGAAAAG 104 Shei et al., 2013 
 Reverse ACCAGAGGCATACAGGGACA   
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The primers for the target genes and β-actin were designed by Shei et al., 2013 using 
Primer 3 primers design software. The forward and reverse primers were designed to be 
located on separate exons with a large intron in between to exclude amplification of 
genomic DNA.  
 
The Basic Alignment Search Tool (BLAST) was used to confirm that each primer set was 
specific to the target mRNA transcript in the Mus musculus genome (Appendix 1.7.1). All 
the primer sets were synthesised by Inqaba biotech.  
 
For all PCR experiments, a 20 µl reaction consisted of 1 µl cDNA; 2 µl Taq buffer 
containing (NH4)2SO4 MgCl2; 2 µl 2mM dNTPs, 1.8 µl 25mM MgCl2, 0.5 µl 10mM 
forward primer, 0.5 µl 10mM reverse primer (Appendix 1.7), 0.2 µl Taq recombinant DNA 
polymerase (5 units/µl) and 12 µl nuclease free water. A Bio-Rad My cycler™ thermal 
cycler was used for all PCR experiments with the following cycling parameters: 
denaturation at 95°C for 3 minutes; followed by 40 cycles of 95°C for 30 seconds; 58°C for 
30 seconds; and 73°C for 90 seconds; followed by an additional elongation step of 72°C for 
10 minutes. 
 
All PCR reagents were purchased from Thermo Scientific, USA. A NTC control in which 
cDNA was replaced by nuclease free water was added to each run as a negative control. 
PCR amplification products were centrifuged briefly and stored at -20°C.  
 
2.7.1 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to visualise the PCR products and to confirm the 
presence of each gene in corneal endothelial cells at various stages of development. PCR 
products were separated on a 1.5% TopVision agarose gel (Appendix 4.1h) containing 5 
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µg/mL ethidium bromide. The gels were run in 1x Tris-base EDTA (TBE) running buffer 
(Appendix 3.1i) by electrophoresis at 85 V for 45 minutes. An O’GeneRuler™ DNA 
molecular weight marker (MW) (range 100-10 000 bp, Thermo Scientific, USA) was 
loaded into the first lane of every gel to identify product sizes. 2 µl 6X loading dye 
(Thermo Scientific, USA) was added to 8 µl PCR product which was then loaded into a 
single well in the gel. Gels were visualised and bands were detected under UV light in a 
Bio-Rad Chemidoc® XRS+ imaging system (Bio-rad, USA). Image Lab™ software (Bio-
rad, USA) was used to analyse detected bands.  
 
2.8 Real-time quantitative PCR (qPCR) 
Once the efficacy of the primer sets were evaluated by conventional PCR, qPCR was used 
to determine the relevant expression levels of the target genes using the Applied 
Biosystems 7500 Real-Time PCR System with HID Real-Time PCR Analysis Software 
version 1.2. 
 
SYBR® Green is a commonly used fluorescent dye that binds to double-stranded DNA and 
can be monitored by measuring an increase in fluorescence. SYBR® green dye for detection 
was used in a 25 µl reaction that consisted of 12.5 µl SYBR® Green JumpStart™ Taq 
ReadyMix™ mastermix (Sigma-Aldrich®, USA); 10.5 µl nuclease free water, 0.5 µl 10mM 
forward primer; 0.5 µl 10mM reverse primer ans 1µl cDNA. SYBR® Select Master Mix 
(Applied Biosystems) was later used which required a 20 µl reaction that consisted of 10 µl 
SYBR select, 8 µl nuclease free water, 0.5 µl 10mM forward primer; 0.5 µl 10mM reverse 
primer and 1 µl cDNA. Reactions were transferred into a MicroAmp®Optical 96-well 
Reaction Plate (Applied Biosystems) in triplicate, which was gently centrifuged at 500 rpm 




The following cycling parameters were used to amplify the target genes: an initial 
denaturation at 95°C for 10 minutes; followed by 45 cycles of denaturation at 95°C for 30 
seconds; annealing at 58°C for 30 seconds; and extension at 72°C for 45 seconds. SYBR 
Select Master Mix required an additional activation temperature at 50°C for 2 minutes 
before the initial denaturation at 95°C for 10 minutes. The rest of the cycling parameters 
remained the same as those used for SYBR® Green JumpStart™ Taq ReadyMix™. A melt 
curve analysis ranged from 50°C to 90°C with 1°C increments and a plate read step was 
included for 5 seconds after each temperature change (Appendix 1.8). 
 
The expression levels of the target genes were normalised against that of the two reference 
genes Hprt and β-actin. Relative quantification using the comparative Ct method was used 
to analyse the data. Values given are expressed as a fold change relevant to the control cell 
line (E12.5) as determined by the 2-ΔΔCt method (Livak and Schmittgen, 2001). All qPCR 
experimental procedures used in this study were performed in accordance with the MIQE 
guidelines (Appendix 1). 
 
2.8.1 Statistics 
qPCR data were analysed using (IBM) SPSS Statistics Version 21. Differences in 
expression of the target genes between the different developmental stages were determined 
using a One Way Analysis of Variance (ANOVA) and a Tukey HSD post-hoc test. All tests 




2.9 Polyacrylamide gel electrophoresis (PAGE) and immunoblot analysis 
 
2.9.1 Protein extraction and sample preparation  
Protein was extracted from E12.5; E13.5; E15.5 and P13 cell lines. Protein could not be 
extracted from E14.5 cells as the cell line was lost due to failure of the liquid nitrogen stock 
freezer.  
 
Culture media from selected dishes was aspirated and discarded. Adherent corneal 
endothelial cells were then harvested from two 10 cm3 dishes per cell line using a cell 
scraper (Biologix Research Company). The dishes were rinsed with 1x PBS to collect the 
cells, which were then transferred into a single sterile 15 mL centrifuge tube per cell line. 
The 15 mL centrifuge tube was centrifuged at room temperature for 5 minutes at 2000 rpm 
in an Eppendorf 5810 R centrifuge. The supernatant was discarded and the pellet of cells 
was re-suspended in 1 mL 1x PBS which was centrifuged for a further 2 minutes at 4°C at 
2000 rpm. The supernatant was discarded and the pellet of cells was placed on ice 
immediately.  
 
Each pellet of cells was resuspended in 50 µl Radio-immunoprecipitation assay (RIPA) 
buffer (Sigma-Aldrich®, USA) and 5 µl of a protease and phosphatase inhibitor cocktail 
(Sigma-Aldrich®, USA), which was then mixed by vortexing at medium speed. The cells 
were then incubated at room temperature for 5 minutes, followed by a 30 minute incubation 
period on ice. The tube was centrifuged at 4°C for 15 minutes at 4000 rpm. The quantity of 
cell lysate removed from each tube was recorded. 10 µl of each lysate was placed in a 
separate sterile micro-centrifuge tube for protein quantification. An equal volume of 
reducing sample treatment buffer/protein loading dye (Appendix 4.2a and 4.2b) was added 
to the remaining cell lysate (1:1 ratio). Protein samples were centrifuged briefly and 
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incubated at 95°C for 5 minutes. Thereafter the protein samples were vortexed briefly, 
centrifuged and stored at -80°C. 
 
2.9.2 Protein quantification  
A Pierce® Bicinchoninic Acid (BCA) Protein Assay Kit (Thermo Scientific) was used to 
quantify all protein samples according to the ‘microplate procedure’. 
 
2.9.2.1. Preparation of BCA standards 
The BCA kit provides protein standards that can be diluted and used to generate a standard 
curve of known concentrations. Each ampule provided has a concentration of 2 mg/mL. 
300 µl of 2000 µg/mL BCA stock was serially diluted into 7 micro-centrifuge tubes. A 
blank standard containing ultra-pure water was also prepared. 
 
2.9.2.2 Preparation of BCA working reagent (WR) 
The 10 µl lysate dedicated for protein quantification was diluted with nuclease free water in 
a 1:10 ratio (10 µl lysate in 90 µl nuclease free water). The diluted lysate was centrifuged 
briefly and kept on ice until needed. The total working reagent (WR) volume required for 
protein quantification, consisting of Reagent A and Reagent B, was calculated using the 
following equation:  
 
Total WR = [(number of standards x number of replicates) + (number of samples x number 
of replicates) + 1 for pipetting error] x 200 µl 
The total WR was prepared by mixing Reagent A and Reagent B in a 50:1 ratio 
respectively (50 Reagent A: 1 Reagent B) in a 15 mL centrifuge tube. 
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2.9.2.3 The microplate procedure 
The BCA standards and protein lysate samples were thawed on ice and briefly centrifuged. 
25 µl of each standard and samples were pipetted into a 96-well microplate (Sero-Well) in 
duplicate and triplicate respectively. 200 µl of WR was pipetted into each well containing 
standards or samples and the plate was gently agitated for 30 seconds. The microplate was 
then sealed and incubated at 37°C for 30 minutes. The microplate was left to cool to room 
temperature and read on a microplate reader (Powerwave XS plate reader, Bio-Tex®) using 
KC4™ version 3.2 software. Absorbance readings were measured at 562nm and a standard 
curve was generated by the software. The unknown protein concentrations were then 
extrapolated from the standard curve (Figure 2.2) 
 
Figure 2.2: BCA standard curve used to extrapolate unknown protein concentrations.   
2.9.3 Polyacrylamide gel assembly 
A Mini-PROTEAN 3 cell system (PowerPac Basic™, Bio-Rad) was used for PAGE 
analysis. Glass plates (1.5 mm) used to assemble the gels were cleaned thoroughly with 
70% ethanol. Parafilm (Pechiney Plastic Packaging) was used to seal the glass plates, 
which were then inserted into a casting frame (Bio-Rad) and secured in a casting stand 
(Bio-Rad) (Figure 2.3). 
y = 1.1335x + 0.1056 




























Figure 2.3: Polyacrylamide gel assembly apparatus. Image adapted from www.bio-rad.com 
 
12.5 % SDS polyacrylamide gels (Appendix 4.2c) were used to resolve the proteins of 
interest in this study. The resolving gel components were combined in a 15 mL centrifuge 
tube and mixed by gently inverting the tube, thus preventing SDS foaming and bubble 
formation. The resolving gel was promptly loaded between the sealed glass plates using a 
Gilson pipette. Thereafter, 1 mL of ultra-pure water (Milli-Q® Integral 3/5/10/15 system) 
was gently pipetted in a drop wise manner on top of the resolving gel to form a layer that 
will trap any air bubbles formed in the resolving gel. The resolving gel was left to set for 25 
minutes. Thereafter, the plates were removed from the casting stand and the ultra-pure 
water was poured off. Residual water was absorbed by a piece of sterile filter paper, paying 
careful attention not to pierce the resolving gel. The plates and casting frame were secured 




4% stacking gels (Appendix 4.2c) were prepared in a 15 mL centrifuge tube. The 
components were mixed by gently inverting the tube and promptly pipetted onto the solid 
resolving gel secured in the casting frame. A 15-well comb was inserted into the stacking 
gel and allowed to set for 25 minutes. Thereafter, the plates were removed from the casting 
stand and frame, and the parafilm and comb were removed as well. The wells of the gel 
were gently rinsed with 1x electrode buffer (Appendix 4.2d) using a 1 mL pipette. Excess 
gel fragments were removed from the surface of the glass plates before they were placed 
into the electrode assembly apparatus. The entire electrode assembly apparatus was then 
placed in a tank filled with 1x electrode buffer, with the smaller plate facing inwards. The 
entire tank was then placed into a Tupperware container that was filled with ice to prevent 
overheating during electrophoresis. 
 
2.9.3.1 Sample preparation and loading into the gel 
Protein samples were thawed from -80°C at 95°C for 5 minutes. Thereafter, protein 
samples were centrifuged at room temperature for 2 minutes at 2000 x g and allowed to 
cool to room temperature. 2.5 µl of a PageRuler™ Prestained Protein Ladder (Thermo 
Scientific) was loaded into the first and last wells in each gel. 40 µg of protein was loaded 
in duplicate in each gel. 
 
2.9.3.2 PAGE gel electrophoresis and protein transfer 
The protein samples were run through the 4% stacking gel at 90 V for 30 minutes in the 
Mini-PROTEAN 3 cell system (PowerPac Basic™, Bio-Rad). Thereafter, the protein 
samples were separated by the resolving gel at 120 V for 60 minutes.  
 
After PAGE gel electrophoresis, the glass plates containing the gels were removed from the 
tank and placed in a container containing sufficient protein transfer buffer (Appendix 4.2e) 
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to keep the gels moist. A gel releaser was used to carefully separate the glass plates and 
loosen the gel. The stacking gel was discarded and the protein transfer cassette was laid out. 
A foam sponge (Bio-Rad) was soaked in protein transfer buffer and placed on the black 
side of the protein transfer cassette. Four pieces of pre-cut filter paper were also soaked in 
protein transfer buffer and placed on the foam sponge individually. A 1 mL pipette tip 
(TipOne, Starlab) was used to smoothen out the filter paper and remove air bubbles (air 
bubbles would result in an uneven protein transfer). The gel was carefully placed on top of 
the fourth piece of filter paper. A pre-cut sheet of Amersham™ Hybond™-ECL 
nitrocellulose membrane (GE Healthcare) was gently soaked in protein transfer buffer and 
placed on top of the gel. An additional four pieces of pre-cut paper were soaked in protein 
transfer buffer and placed on the nitrocellulose membrane to keep the gel and the 
membrane moist. Air bubbles were smoothened out. Another foam sponge was soaked in 
protein transfer buffer and placed on the filter paper stack. The protein transfer cassette was 
closed and placed into the electrode assembly apparatus in the tank filled with protein 
transfer buffer. A magnetic stirrer was placed in the tank. The entire tank was placed in a 
Tupperware container which was then placed on an IKA® big-squid stirrer. An ice brick 
was placed inside the tank, in contact with the protein transfer cassette, and ice was stacked 
in the Tupperware container around the tank to prevent over-heating. The protein transfer 
was then run at 100 V for 80 minutes to completely transfer the protein from the gel onto 
the nitrocellulose membrane.  
 
2.9.3.3 Membrane blocking and antibody incubations 
Protein expression could not be determined for Slc4a4 due to the lack of a commercially 
available antibody specific for mouse Slc4a4. For Zo1, the membrane was probed with a 
primary polyclonal antibody specific for mouse Zo1, and subsequently probed with a 
secondary horseradish peroxidase HRP antibody. For Aqp1, the membrane was probed 
with a primary polyclonal antibody specific for mouse Aqp1, and subsequently probed with 
a secondary HRP antibody.  
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After the protein transfer was completed, the protein transfer cassette was dismantled and 
the nitrocellulose membrane was cut into 3 strips, with first strip containing the Zo1 protein 
at ~220 kDa, the second strip containing the glycosylated Aqp1 protein at ~35 kDa and the 
third strip containing the unglycosylated Aqp1 protein at ~35 kDa. A single protein transfer 
onto 1 nitrocellulose membrane could then be incubated with 3 separate antibodies for 
different proteins.  The strips of nitrocellulose membrane containing each protein were 
placed in separate containers. The membranes were rinsed twice in Tris-Buffered Saline 
with tween (TBS-T; Appendix 4.2f) to remove any traces of protein transfer buffer and to 
keep the membranes moist. The membranes were then incubated in 6% skim milk (Sigma-
Aldrich®, USA) blocking solution (Appendix 3.2g) for an hour with agitation (MiniMix, 
Enduro™, Labnet). Blocking prevents non-specific primary antibody binding. Thereafter, 
the membranes were rinsed twice in TBS-T to remove traces of blocking solution. Residual 
TBS-T was aspirated with a 1 mL pipette.   
 
Following blocking, the membranes were probed with the following primary antibodies: 
Table 2.2: Antibodies (AB) used in this study for western blot analysis.  
Protein 1° AB Name 1° AB dilution 2°AB Name  2°AB Dilution 
Zo1 ZO-1 (H-300): sc-10804 
Santa Cruz Biotechnology, Inc 
1:1000 Anti-rabbit IgG, HPR-
linked. Cell Signaling 
Technology® 
1:4000 
Aqp1 Anti-AQP1 (#AB2219) 
Millipore 
1:2000 Anti-rabbit IgG, HPR-
linked. Cell Signaling 
Technology® 
1:4000 
*All primary antibodies were diluted in 6% skim milk (Sigma-Aldrich®, USA) and all 




The membranes were incubated with primary antibodies overnight at 4°C with agitation on 
an IKA® KS 130 Basic at 160 rpm. 
 
The following day, the membranes were rinsed with TBS-T 3 times to remove all traces of 
the primary antibodies. The membranes were then soaked in TBS-T for 8 minutes on the 
IKA® KS 130 Basic at 320 rpm. These 8 minute washes were repeated 3 times for Zo1 and 
glycosylated Aqp1, and twice for unglycosylated Aqp1 (more than 2 washes reduced the 
intensity of the unglycosylated band). In between each wash, the membranes were 
vigorously rinsed with fresh TBS-T twice. These washes ensure that unbound or non-
specifically bound primary antibodies are removed. All the TBS-T was aspirated after the 
final wash and the membranes were probed with the secondary antibody (Table 2.2) at 
room temperature for 1 hour with agitation on an IKA® KS 130 Basic at 160 rpm.  
 
Following incubation, the secondary antibody was aspirated and the membranes were 
washed as described for the primary antibody. The 8 minute washes were repeated 3 times 
for Zo1 and glycosylated Aqp1, and twice for unglycosylated Aqp1 to remove non-specific 
secondary antibody binding. 
 
2.9.4 Imaging the western blot 
Protein bands were visualised using a Clarity™ Western ECL Blotting Substrate (Bio-Rad) 
on the ChemiDoc™ XRS+ System using Image lab™ software version 2.0.1 (Bio-Rad). The 
Clarity™ Western ECL Blotting Substrate chemiluminescent detection system (Figure 2.4) 




Figure 2.4: The chemiluminescent detection system. After the primary antibody binds to the 
target protein, a complex with a HPR-linked secondary antibody is formed. The 
chemiluminescent substrate is added and emits light during enzyme catalysed 
decomposition. Image obtained from (http://media.cellsignal.com/pdf/7074.pdf). 
 
Each membrane was imaged separately. The membrane was dabbed on tissue paper to 
remove residual TBS-T and placed on a plastic plate. The plate was then placed into the 
ChemiDoc™ XRS+ System. A chemiluminescent solution was prepared by adding Clarity™ 
Western ECL peroxide solution and Clarity™ Western ECL luminol/enhancer solution in a 
1:1 ratio (300 µl of each solution was used in this study). 600 µl of the prepared 
chemiluminescent solution was pipetted onto the membrane in a drop wise manner and the 
membrane was tilted to ensure an even distribution of the solution. The membranes were 
imaged using a western blot protocol established in the laboratory. The protein ladder was 
then imaged using a Molecular Marker protocol as this is not detected by the 
chemiluminescent signal. The western blot image and the molecular marker image were 
merged and flipped to yield a single representative image that was in the same orientation 
as when the protein was loaded. A single representative image was analysed by 
densitometry. Ponceau S staining was performed to detect total protein on the membrane. 
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The membranes were stained in 1x Ponceau S stain (Sigma-Aldrich®, USA, Appendix 
3.2h) for 5 minutes at room temperature with agitation. A Ponceau destain (Appendix 3i) 
was used to rinse the membranes and remove excess Ponceau S for 30 seconds at room 
temperature with agitation. Total protein was then detected by imaging the membrane using 
the Molecular Marker protocol as done for the protein ladder. A single representative 
Ponceau S image was analysed by densitometry (appendix 2). 
 
2.9.5 Densitometry 
Densitometry was performed on the western blot images using the Image lab™ software 
version 2.0.1 (Bio-Rad). A rectangle was constructed around each protein band (same size) 
which allowed the software to calculate the local pixel or band intensity of each band. This 
was repeated on the Ponceau S image to analyse total protein. The band intensities were 
exported into Microsoft Excel 2010 and the intensity of the gene of interest (i.e. Zo1 and 
Aqp1) was calculated relative to the intensity of the total protein (i.e. Ponceau S).  The 
results are expressed as an average with the standard error of the mean (SEM). 
Densitometric data were analysed using (IBM) SPSS Statistics Version 21. Differences in 
expression of the target genes between the different developmental stages were determined 
using a One Way Analysis of Variance (ANOVA) and a Tukey HSD post-hoc test. All tests 
for normality were satisfied and significance was determined at p˂0.05. 
 
2.10 Immunocytochemistry - confocal microscopy 
 
Confocal microscopy was performed to evaluate the localisation of Zo1 and Aqp1 protein 
expression at E12.5, E13.5, E15.5 and P13 cell line in monolayer culture as well as hanging 





2.10.1 Monolayer culture 
 
The cell lines from each developmental stage were cultured in 10 cm3 dishes. Culture 
medium was aspirated and the cells were harvested by gently scraping the cells using a cell 
scraper (Biologix Research Company). The dishes were rinsed with 1x PBS to collect the 
cells, which were then transferred into a single sterile 15 mL centrifuge tube. The 15 mL 
centrifuge tube was centrifuged at room temperature for 5 minutes at 2000 rpm. The 
supernatant was discarded and the pellet of cells was re-suspended in 1 mL culture 
medium. Cell counts were performed using a haemocytometer and a Nova compound light 
microscope (Novatech, USA). 1x103 cells were seeded onto UV treated 12 mm coverslips 
placed into each well of a 24-well plate, supplemented with 1 mL of culture medium. 
Monolayers were cultured under normal cell culture conditions (as described in section 2.5) 




2.10.2 Hanging drop culture 
 
Cells were harvested and counted as described in section 2.10.1. The hanging drops were 
generated by pipetting 30 µl drops of culture medium containing 1x103 cells on the inverted 
lid of a 6 cm3 dish (Corning, USA). 3 mL 1x PBS was added to the culture dish to prevent 
desiccation of the drops. The lid was then carefully inverted and placed on the base of the 
dish and the hanging drops were cultured for 72 hours. Cell growth was monitored using a 
Nikon TMS-F inverted light microscope (Nikon, Japan).  
 
 
12 mm glass coverslips were coated with 2 µl Poly-L-lysine (Sigma-Aldrich®, USA) to 
facilitate cell adhesion of the hanging drops to the coverslips prior to fixation. The hanging 
drops were gently transferred onto the coated glass coverslips using forceps. The forceps 
were used to hold the glass coverslips against the lid containing the hanging drops. The 
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medium containing the hanging drops were gently transferred onto the glass coverslips 
upon contact. Excess medium around the hanging drops was carefully aspirated by 
pipetting the medium off the coverslips, paying careful attention not the contact the hanging 
drops with the pipette tip. The glass coverslips containing the hanging drops were left to air 




2.10.3.1 Sample preparation of the monolayer and hanging drop cultures   
Culture medium in the wells of the plate was aspirated and discarded. The cells in the wells 
were gently washed with 200 µl 1x PBS using a Pasteur pipette rested against the well wall 
(to prevent washing the cells off the coverslip).  Monolayers and hanging drops were fixed 
in the wells with 4% paraformaldehyde (Merck, USA, Appendix 3.3a) at room temperature 
for 10 minutes, followed by 3 washes with 200 µl 1x PBS. Thereafter, the cells were 
blocked in 0.5% bovine serum albumin (BSA) blocking solution (Appendix 4.3b) at room 
temperature for 1 hour.  
 
2.10.3.2 Antibody incubations 




Table 2.3: Antibodies (AB) used in this study for immunocytochemistry analysis.  
Protein 1° AB Name 1° AB dilution 2°AB Name 2°AB 
Dilution 
Zo1 ZO-1 (H-300): sc-10804 
Santa Cruz Biotechnology, Inc 
1:50 Cy™3-conjugated donkey 
anti-rabbit IgG. 
Jackson Immunolabs, USA.   
1:1000 
Aqp1 Anti-AQP1 (#AB2219) 
Millipore 
1:2000 Cy™3-conjugated donkey 
anti-rabbit IgG. 
Jackson Immunolabs, USA.  
1:1000 
The primary and secondary antibodies were diluted in 0.5% BSA (Sigma-Aldrich®, USA) 
solution.  
 
The cells were incubated in 300 µl primary antibody solution at 4°C overnight. The 
following day, primary antibody solutions were aspirated and the wells were rinsed with 
200 µl of cold 1x PBS 3 times to remove all traces of the primary antibodies. The cells 
were then incubated with Cy™3-conjugated donkey anti-rabbit IgG secondary antibody in 
the dark for 1 hour at room temperature. Following incubation, the secondary antibody was 
aspirated and the wells were rinsed with 200 µl 1x PBS 3 times to remove all traces of the 
secondary antibodies. The cells were then incubated with 300 µl of a 1:50 dilution of 50 
µg/mL 4’6,-diamidino-2-phenylindole (DAPI) in 1x PBS for 5 minutes at room 
temperature to stain the nuclei. The cells were then rinsed once with 200 µl 1x PBS and the 
coverslips were mounted on glass slides using a drop of mowial with 1,4-diazabicyclo 
[2.2.2]octane (DABCO) mounting medium (Appendix 4.3c and 4.3d). Mounted slides were 




For the negative controls, primary and secondary antibodies were substituted by 1x PBS in 
no-primary controls and no-secondary controls respectively, to identify non-specific 
binding of each antibody (appendix 3). 
2.10.4 Visualisation 
Zo1 and Aqp1 monolayers and hanging drops were analysed by confocal microscopy using 
a Zeiss LSM 710 Laser Scanning Confocal Microscope (Zeiss, Germany) at the UKZN 
Centre for electron microscopy (UKZN Pietermaritzburg campus). Images were captured 
using ZEN Efficient Navigation 2010 software (Zeiss, Germany).The slides were viewed 
under Lcl PlanNeoFluar 25x/0.8 1 mm Korr DIC M27 and 63x/1.3 1 mm Korr DIC M27 
objectives. The frame size maintained at 1024 x 1024 and images were taken at speed 3 
with an averaging of 4. The pin hole was maintained at 1 airy unit. The laser intensity for 
DAPI and Cy3 was maintained at 4 and 20 respectively to ensure that images between 
developmental stages were comparable. 
 
2.11 Foxc1 knockdown using the pSilencer™ hygro kit. 
 
2.11.1 Overview  
Previously in the laboratory, we generated a shRNA targeting Foxc1 that was shown to 
knock down Foxc1 expression by 99% (Silla et al., 2014). The siRNA was cloned into 
pGEMTeasy and therefore can only be used for transient transfections. One of the aims of 
this study (although not achieved) was to clone the siRNA sequence into a vector that 
allows for stable knockdown.  We chose the pSilencer®2.1-U6 hygro vector (Figure 2.5) 
that uses RNA polymerase III (pol III) promoters which produce large amounts of small 
RNA using promoter and terminator sequences. The plasmid used in this study includes 
both Hygromycin and Ampicillin antibiotic resistance genes for selection (Figure 2.5). The 
plasmid is also linearised with both BamH 1 and Hind III restriction sites to facilitate 




Figure 2.5: pSilencer hygro vector map. Image obtained from www.lifetechnologies.com 
 




2.11.2 Foxc1-shRNA sequence 
Previously, with the aid of Prof. Marco Weinberg from The University of Witwatersrand, 
we designed an shRNA that targets Foxc1 and knocks down its expression effectively 
(Figure 2.7) (Silla et al., 2014).  These oligonucleotide sequences were modified to 
incorporate additional sequences for BamH 1 and Hind III on the 5’ and 3’ ends of the 
siRNA sequence respectively, synthesised and PAGE purified. The total length of the 
modified oligonucleotides was 65bp.   
 
Figure 2.7: shRNA-2-Foxc1.  
2.11.3 Cloning hairpin siRNA inserts into the pSilencer vector  
2.11.3.1 Oligonucleotide annealing and ligation 
Sense and antisense siRNA template oligonucleotides were dissolved in nuclease free water 
to yield a 100 µM stock solution. The concentration of each oligonucleotide was quantified 
using a Spectrophotometer ND1000 (NanoDrop technologies). Each oligonucleotide was 
then diluted to prepare a 1 µg/µl solution in nuclease free water. An annealing mixture was 
prepared by mixing 2 µl of each oligonucleotide in 46 µl 1x DNA Annealing solution 
(pSilencer™ hygro kit) in a sterile 1.5 mL micro-centrifuge tube. The annealing mixture 
was heated to 90°C for 3 minutes in a dry bath incubator, after which it was incubated at 
37°C for 1 hour. The annealed siRNA hairpin template was then ligated into the pSilencer 
vector as follows: 5 µl of the annealed siRNA hairpin template insert was diluted in 45 µl 
nuclease free water for a final concentration of 8 ng/µl. A 10 µl plus-insert ligation reaction 
was set up in a micro-centrifuge by mixing 1 µl of the diluted annealed siRNA insert, 6 µl 
nuclease free water, 1 µl 10x T4 DNA ligase buffer (Promega), 1 µl pSilencer vector and 
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1.7 µl T4 DNA ligase (3 u/µl) (Promega). A 10 µl minus-insert ligation reaction was set up 
as a negative control by replacing the diluted annealed siRNA insert with 1x DNA 
Annealing solution. The plus and minus insert ligation reactions were incubated overnight 
at 16°C to facilitate a very high ligation efficiency.  
 
2.11.3.2 Plasmid transformation 
DH5a Z-Competent™ Eschericia Coli (E.coli) cells (Zymo Research) that were stored at -
80°C were briefly thawed on ice. A 50 µl aliquot of competent E.coli cells was transformed 
with 5 µl minus-insert ligation product in a 1.5 mL microcentrifuge tube. A second aliquot 
of competent E.coli cells was transformed with 5 µl plus-insert ligation product in a 1.5 mL 
microcentrifuge tube. The tubes were gently flicked to mix the cells which were then 
pipetted onto the centre of pre-warmed ampicillin-containing Luria broth (LB) agar plates 
(Appendix 4.4a) (1 plate per treatment) and spread using the aseptic technique. The minus-
insert ligation product was plated first to avoid cross contamination from the plus-insert 
ligation product. The ampicillin agar plates were incubated at 37°C overnight to facilitate 
cell transformation. The following day, individual colonies were isolated by gently scraping 
them off the agar with a pipette tip. The selected colonies were grown in 10 mL LB broth 
(Appendix 4.4b) containing ampicillin (1 µl of 100 mg/ml ampicillin per 1 mL LB broth) in 
a 50 mL centrifuge tube (Corning, USA) overnight at 37°C with agitation in a shaking 
incubator (225 rpm). The following day, 1 mL glycerol stocks of each colony was prepared 
and stored at -20°C (Appendix 4.4c). This ensured that samples that contained the positive 
insert could be propagated later. Plasmid DNA was then purified. 
 
2.11.3.3 Plasmid mini-prep 
Plasmid DNA was initially purified from transformed E.coli cells using a QIAprep Spin 
Miniprep kit (QIAGEN, Germany). The 50 mL centrifuge tubes containing the colonies in 
LB broth were removed from the shaking incubator and cells were harvested by 
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centrifugation at 1 000 x g for 10 minutes at 4°C in an Eppendorf 5218R centrifuge. The 
supernatant was discarded and the pellet of cells was re-suspended in 250 µl buffer P1 
supplemented with RNase A and LyseBlue. The solution was mixed by pipetting and 
transferred into a sterile 1.5 mL micro-centrifuge tube. The micro-centrifuge tube was 
inverted several times to homogenise the solution. The cell suspension turned blue which 
indicated a homogeneous solution. 250 µl buffer P2 was added to the solution and mixed 
by inverting the tube 4-6 times. 350 µl buffer N3 was added and the tube was inverted 4-6 
times to thoroughly mix the solution. The tube was then centrifuged at room temperature at 
10 000 rpm for 10 minutes to yield a compact white pellet. The supernatant was aspirated 
and added directly into a QIAprep spin column by pipetting. The QIAprep spin column was 
briefly centrifuged at room temperature at 10 000 rpm for 30 seconds and the flow-through 
was discarded. 750 µl buffer PE (wash buffer) was added to the QIAprep spin column, 
which was then centrifuged at room temperature at 10 000 rpm for 30 seconds to wash the 
spin column. The flow-through was discarded and the spin column was centrifuged at room 
temperature at 10 000 rpm for 1 minute to remove residual wash buffer. The flow-through 
and collection tube were discarded and the spin column was placed in a sterile 1.5 mL 
micro-centrifuge tube. To elute the DNA, 30 µl TE buffer (Appendix 4.4d) was pipetted 
directly onto the membrane in the centre of the spin column. This was left to stand at room 
temperature for 5 minutes. Thereafter the spin column was centrifuged at room temperature 
at 10 000 rpm for 1 minute. The spin column was then discarded and the purified plasmid 
DNA was stored on ice until it was quantified using a Spectrophotometer ND1000 
(NanoDrop technologies). The plasmid DNA was then stored at -20°C.  
 
2.11.3.4 PCR amplification to verify that the clones contained the siRNA insert 
T7 sequencing primers were used for conventional PCR to verify that the clones contained 
the siRNA insert (Appendix 4.4e). The primer sequences were as follows: forward 5’-GTA 
ATA CGA CTC ACT ATA GGG-3’; reverse 5’-AGG CGA TTA AGT TGG GTA-3’. A 
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temperature gradient PCR was performed to optimise the melting temperature of the T7 
primers (Figure 2.8).  
 
 
Figure 2.8: A temperature gradient PCR of the T7 primers showing the optimal melting 
temperature at 57.3°C.  
 
A 20 µl reaction consisted of 1 µl plasmid DNA; 2 µl Taq buffer containing (NH4)2SO4 
MgCl2; 2 µl 2mM dNTPs, 1.8 µl 25mM MgCl2, 0.5 µl 10mM forward primer, 0.5 µl 10mM 
reverse primer, 0.2 µl Taq recombinant DNA polymerase (5 units/µl) and 12 µl nuclease 
free water. A Bio-Rad My cycler™ thermal cycler with the following cycling parameters: 
denaturation at 95°C for 3 minutes; followed by 40 cycles of 95°C for 30 seconds; 57.3°C 
for 30 seconds; and 73°C for 90 seconds; followed by an additional elongation step of 72°C 
for 10 minutes. PCR products were analysed by agarose gel electrophoresis as explained in 
section 2.7.1 of the materials and methods.  
 
2.11.3.5 Digestion of purified plasmid DNA  
The purified plasmid DNA was digested with restriction enzymes to verify that the clones 
contained the plasmid insert. Each DNA sample was prepared for digestion as follows: 1 µg 
plasmid DNA; 1 µl BamH I restriction enzyme (10 u/µl) (Thermo Scientific); 1 µl Hind III 
restriction enzyme (10 u/µl) (Thermo Scientific) and 2 µl 10x Tango buffer (Thermo 
Scientific) was added to a 1.5 mL micro-centrifuge tube. Nuclease free water was then 
added to the reaction to make up a final volume of 20 µl. The tube was then incubated in a 







incubation, the tubes were centrifuged briefly and the restriction products were separated 
on a 1.5% agarose gel by electrophoresis as described in section 2.7.1. The presence of 2 
bands should indicate that the clones contain the siRNA insert. A band at approximately 
4900bp would represent the vector and a 65bp band would represent the insert.  
 
2.11.4 Troubling shooting  
Due to the small size of the siRNA insert (65bp) and the low concentration of the plasmid 
DNA obtained from a mini-prep, further trouble shooting was performed to distinguish the 
presence of the small siRNA insert. 
 
2.11.4.1 Native polyacrylamide gel electrophoresis (PAGE) 
Despite numerous attempts, the siRNA insert (65bp) could not be detected by agarose gel 
electrophoresis following digestion with restriction enzymes. Therefore, native 
polyacrylamide gel electrophoresis was performed to resolve the restriction products. 
Native PAGE gels resolve DNA instead of protein and differ from conventional PAGE gels 
as SDS is replaced by water (Appendix 4.4f). The restriction products were separated on an 
8% native PAGE gel run in 1x TBE buffer at 100V for 80 minutes. Clones that contained 
the siRNA insert were subjected to midi-prep purification to yield a greater concentration 
of plasmid DNA.  
 
2.11.4.2 Plasmid midi-prep 
Super Optimal Broth (SOB) with catabolite repression (SOC) (i.e. SOB with added 




A starter culture of 100 mL SOC medium (Appendix 4.4g) was transferred into a 200 mL 
glass Schott bottle. 10 µl of the plasmid from the glycerol stock was added to the culture, 
which was then incubated at 37°C overnight with agitation in a shaking incubator (225 
rpm). The following day, 50 mL of the culture was transferred into a 50 mL centrifuge tube 
(Corning, USA) and centrifuged at 10 000 rpm for 30 minutes at 4°C to pellet the cells. The 
supernatant containing the SOC medium was discarded and the remaining 50 mL of culture 
was added into the same centrifuge tube that contains the cell pellet. The tube was 
centrifuged again at 10 000 rpm for 30 minutes at 4°C to pellet the cells in the remaining 
culture. The supernatant containing the SOC medium was discarded and the pellet was 
purified using a QIAGEN midi-prep kit (QIAGEN, Germany).  
 
The pellet was re-suspended in 4 mL buffer P1 containing RNase A and LyseBlue. The 
solution was mixed by pipetting and transferred into a sterile 15 mL centrifuge tube. The 
centrifuge tube was vigorously inverted several times to homogenise the solution. The cell 
suspension turned blue which indicated a homogeneous solution. Thereafter, 4 mL buffer 
P2 was added to the solution and mixed by inverting the tube 4-6 times until the solution 
tuned white.  Thereafter, 4 mL buffer P3 was added and the tube was vigorously inverted 4-
6 times to thoroughly mix the solution. The tube was incubated on ice for 15 minutes, 
followed by centrifugation at 4°C at 10 000 rpm for 30 minutes to yield a compact white 
pellet containing cellular debris. A layer of cell debris was carefully removed and the 
supernatant containing the plasmid DNA was aspirated promptly and added directly into a 
QIAGEN-tip 100 that had been equilibrated with 4 mL buffer QBT. The QIAGEN-tip 100 
containing the supernatant was balanced over a glass beaker to filter the supernatant 
through the membrane by gravity flow. The QIAGEN-tip 100 membrane was washed twice 
with 10 mL buffer QC. The QIAGEN-tip 100  was placed into a sterile 15 mL centrifuge 
tube and the plasmid DNA was eluted from the QIAGEN-tip 100 membrane by adding 5 
mL buffer QF directly onto the membrane. The plasmid DNA was then precipitated by 
adding 3.5 mL of room temperature isopropanol (Merck), followed by centrifugation at 10 
000 rpm at 4°C for 30 minutes. The supernatant was carefully aspirated and discarded. 2 
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mL 70% ethanol was added to wash the cell pellet which was then centrifuged at 10 000 
rpm at 4°C for 10 minutes. The supernatant was carefully aspirated and discarded, and the 
cell pellet was left to air dry for 5 minutes. The cell pellet was dissolved in 30 µl TE buffer 
and stored on ice until it was quantified using a Spectrophotometer ND1000 (NanoDrop 
technologies). The plasmid DNA was then stored at -20°C. 
 
2.11.5 Sequencing 
Clones containing the siRNA insert were verified by Sanger sequencing (Inqaba Biotec™, 
South Africa) using T7 primers (Appendix 4.4e). BiQ Analyzer Software version 2.00 was 
used to compare the clonal sequences to the oligonucleotide design to determine sequence 
homology between the two (Bock et al., 2005). Despite numerous attempts to sub-clone the 
siRNA sequence into pSilencer, this was not achieved within the time frame of this 





3.1 Establishment of immortalised murine corneal endothelial cultures at various 
stages of development  
Mesenchyme cells, derived from predominantly neural crest with contributions from lateral 
plate mesoderm, are collectively known as periocular mesenchyme (POM) (Beebe and 
Coats, 2000, Langenberg et al., 2008). Fate mapping studies have shown that these POM 
cells contribute to the development of the corneal endothelium as well as other key 
structures in the anterior segment of the eye during embryogenesis (Ittner et al., 2005). 
  
In the mouse, the corneal endothelium develops from a population of POM cells that 
migrate into the region between the surface ectoderm and the lens vesicle in the anterior 
segment of the eye at E12.5 (Kidson et al., 1999, Ittner et al., 2005). From E12.5, the POM 
cells undergo a mesenchyme to endothelial transition (MET), finally differentiating into an 
adherent corneal endothelial monolayer at E15.5. 
 
Immortalised POM cultures at E12.5 and E13.5 were successfully established by another 
member of the laboratory. These cell lines have been verified (Silla et al., 2014). In this 
study, immortalised cell lines representing presumptive corneal endothelium (E14.5), 





Figure 3.1: Cell morphology at each stage of development in this model (400x). Scale bar is 
16 µm. 
 
The cells maintained a stellate morphology throughout development in this model. POM 
cells at E12.5 and E13.5 grew in dense layers or clumps of cells. Presumptive corneal 
endothelial cells at E14.5 also grew in dense layers. An image of the cells at E14.5 was not 
obtained as the cell line was lost due to failure of the liquid nitrogen freezer.  Differentiated 
corneal endothelial cells at E15.5 and functional corneal endothelial cells grew in tightly-




3.2 Gene expression analysis 
3.2.1 Validation of RNA integrity 
The cell lines described in section 3.1 were used in gene expression analyses. Total RNA 
was extracted from the cells and reverse transcribed into cDNA that was used for all 
subsequent PCR and qPCR reactions. In accordance with MIQE guidelines (Bustin et al., 
2009), the integrity of the RNA samples were validated by gel electrophoresis before use in 
qPCR analyses. RNA aliquots equivalent to 2 µg were separated on a 1% bleach agarose 
gel (Aranda et al., 2012) supplemented with ethidium bromide. A 1Kb DNA molecular 
weight marker (MW) was loaded into the first well of each gel for reference. The integrity 
of the RNA samples was confirmed by the presence of two distinct bands of 28S and 18S 
murine ribosomal subunit RNA (Figure 3.2). The RNA gel shows that the samples used in 
this study were acceptable for further analysis.  
 
 
Figure 3.2: RNA integrity of samples extracted from the cells at each stage of development. 
1) MW; 2) E12.5; 3) E13.5; 4) MW; 5) E14.5; 6) E15.5; 7) P13. RNA extracted for the first 
biological repeat is shown as a representative image for all the biological replicates.  
 
3.2.2 Efficacy of primer sets confirmed by conventional PCR 
Conventional PCR was used to determine the efficacy of the primer sets and the melting 
temperature (58°C) for Zo1, Aqp1 and Slc4a4 before use in subsequent qPCR analyses. 
Total RNA was extracted from cells and reverse transcribed into cDNA. PCR products 
were separated by electrophoresis as described in the materials and methods section 2.8.1.   
 
     1                 2                  3
      28 S 
 18 S 
 




Figure 3.3:  PCR amplicons showing the efficacy of the primer sets used in this study. 1) 
MW, 2) Zo1 (100bp), 3) Zo1 No template control (NTC), 4) Aqp1 (143bp), 5) Aqp1 NTC, 
6) Slc4a4 (151bp), 7) Slc4a4 NTC. cDNA synthesised from E15.5 cells is shown as a 
representative image for all the cell lines.  
 
The conventional PCR results shown in figure 3.3 validate the efficacy of the primer sets 
used in this study. The Slc4a4 (no template control) NTC control resulted in primer dimers 
which occur when the primer sets anneal. The primer sets for these target genes were 
considered to be suitable for subsequent qPCR analyses. 
  
3.2.3 mRNA expression patterns of key functional genes expressed in immortalised 
murine corneal endothelial cultures at various stages of development 
To establish gene expression profiles of key functional genes during corneal endothelial 
development total RNA was extracted from the cells, reverse transcribed into cDNA and 
qPCR was performed. The expression levels of the target genes were normalised against 
that of two reference genes, Hprt and β-actin. Relative quantification using the comparative 
Ct method was used to analyse the data. Values given are expressed as a fold change 
relevant to E12.5 (reference point) as determined by the 2-ΔΔCt method (Livak and 
Schmittgen, 2001). All qPCR experimental procedures used in this study were performed in 
accordance with the MIQE guidelines (Appendix 1). qPCR reaction efficiencies, presented 
in Appendix 1.10, were shown to be comparable thus allowing for comparison of 
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3.2.3.1 Characterisation of Zo1 mRNA expression levels  
Zo1 is a tight junction protein that facilitates the formation of the resilient monolayer that is 
characteristic of the corneal endothelium. Previous studies have shown that Zo1 is 
expressed very early in embryonic development as it is required for morula to blastocyst 
transformation in the mouse (Wang et al., 2008). Zo1 mRNA expression is a known 
functional marker of mature corneal endothelium (Zhu et al., 2008, Fan et al., 2011, Ju et 
al., 2012).  
 
 
Figure 3.4: The relative fold change in Zo1 mRNA expression in corneal endothelial cells 
at various stages of development. Zo1 was normalised to the geometric mean of two 
reference genes, Hprt and β-actin. Expression values are normalised to E12.5 which is set 
at 1. Values are presented as the mean ± SEM. A dissimilar character (a/b) denotes 
statistical significance (p˂0.05; n=3).  
 
Zo1 mRNA levels decrease gradually, but not significantly, from E12.5 to E15.5. Zo1 is 






























3.2.3.2 Characterisation of Aqp1 mRNA expression levels  
Aqp1 is a water channel protein that mediates transcellular fluid transport. Knockout 
models, as reviewed in chapter 1 (Table 1.1), have provided sufficient evidence for the 
roles of Aqp1 in transcellular fluid transport. Various studies have used Aqp1 expression to 
assess the functional capability of corneal endothelial cells (reviewed by Verkman, 2009). 
 
 
Figure 3.5: The relative fold change in Aqp1 mRNA expression in corneal endothelial cells 
at various stages of development. Aqp1 was normalised to the geometric mean of two 
reference genes, Hprt and β-actin. Expression values are normalised to E12.5 which is set 
at 1.Values are presented as the mean ± SEM. A dissimilar character (a/b/c) denotes 
statistical significance (p˂0.05; n=3). 
 
The expression of Aqp1 was significantly up-regulated (by 2-fold) at E13.5 compared to 
E12.5 (p˂0.05). By E14.5, levels of Aqp1 are then restored to levels similar to those at 
E12.5. Aqp1 expression levels increase by E15.5, and then decrease significantly by P13 































3.2.3.3 Characterisation of SLC4a4 mRNA expression levels  
Slc4a4 is an ion pump that transports cellular bicarbonate ions across plasma membranes. A 
study by Shei et al. (2013) characterised the expression of several Slc4 members in adult 
corneal endothelial cells and reported that Slc4a4 was highly expressed. 
 
 
Figure 3.6: The relative fold change in Slc4a4 mRNA expression in corneal endothelial 
cells at various stages of development. Slc4a4 was normalised to the geometric mean of 
two reference genes, Hprt and β-actin. Expression values are normalised to E12.5 which is 
set at 1. Values are presented as the mean ± SEM. A dissimilar character (a/b) denotes 
statistical significance (p˂0.05; n=3). 
 
Slc4a4 is expressed at low levels during corneal endothelial development. However, it is 
highly expressed at P13 (p˂0.05 when compared to all other cell lines) in the model of 


































3.2.3.4 Verification of the qPCR results obtained for the immortalised cell lines used 
in this study.   
Although all experiments were performed at low and similar passages, we wanted to verify 
that immortalisation did not have an effect on target gene expression. To determine this, we 
performed the same qPCR experiments on primary, non-immortalised cells at E14.5, E15.5 
and P13. Aqp1 expression was used as a representative of all the cell lines.  
 
 
Figure 3.7: The relative fold change in Aqp1 mRNA expression in non-immortalised 
corneal endothelial cells at various stages of development. Aqp1 was normalised to the 
geometric mean of two reference genes, Hprt and β-actin. Expression values are normalised 
to E12.5 which is set at 1. The results depicted represent one experiment.  
 
The gene expression pattern of Aqp1 in non-immortalised cells is similar to immortalised 
cells given that these are primary cells and there was no opportunity to obtain another 
biological replicate [Figure 3.5 (expression in immortalised cells) and 3.7 (expression in 
























expression of Aqp1 at low passage (Figure 3.7). We have previously shown that gene 
expression in low passage immortalised E12.5 and E13.5 cells appear unaffected by 
immortalisation (Silla et al., 2014).  
 
3.3 Protein expression analysis 
3.3.1 Protein expression patterns of Zo1 and Aqp1 determined by western blot 
analysis   
Western blot analysis was performed to establish protein expression profiles of two key 
functional genes during corneal endothelial development. Protein expression could not be 
determined for Slc4a4 due to the lack of a commercially available antibody specific for 
mouse Slc4a4. Furthermore, the E14.5 cell line was lost due to failure of the liquid nitrogen 
stock freezer before protein was extracted from the cells. Consequently, the results of this 
study do not include a protein expression profile for Zo1 and Aqp1at E14.5.  
 
Protein was extracted and separated on a 12.5% SDS PAGE gel, then transferred onto a 
nitrocellulose membrane. For Zo1, the membrane was probed with a primary polyclonal 
antibody specific for mouse Zo1, and subsequently probed with a secondary HRP antibody. 
For Aqp1, the membrane was probed with a primary polyclonal antibody specific for 
mouse Aqp1, and subsequently probed with a secondary HRP antibody. 
 
 
Figure 3.8: Western blot image of Zo1 protein expression at different stages of corneal 
endothelial development. This is a representative image (n=3). 
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A distinct band detected at ~ 220 kDa (Figure 3.8) represents the Zo1 protein found in each 
cell line. Zo1 protein is therefore expressed throughout corneal endothelial development in 
this model, although at different levels.    
 
 
Figure 3.9: Western blot image of glycosylated and unglycosylated Aqp1 protein 
expression at different stages of corneal endothelial development. This is a representative 
image (n=3). 
 
Two distinct bands detected at ~35 kDa and ~28 kDa represent the glycosylated and 
unglycosylated Aqp1 isoforms found in each cell line respectively (Figure 3.9).  
 
A study by Hendriks et al. (2004) reported that protein glycosylation, a post-translational 
modification, is a requirement for Aqp2 transport from the golgi complex to post-golgi 
compartments such as cell membranes. Hendriks et al. (2004) demonstrate that 
glycosylation is required for Aqp2 cell surface expression in kidney type 1 (MDCK-1) cells 
expressing human wild-type Aqp2, and that unglycosylated Aqp2 is localized 
intracellularly (Hendriks et al., 2004).  
 
Given that Aqp1 and Aqp2 have the same substoichiometric glycosylation (Smith et al., 
1994, Hendriks et al., 2004), the structure and function of these two homologs are 
comparable.  In this study, unglycosylated Aqp1 protein was only expressed at E12.5 and 
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E13.5, while glycosylated Aqp1 protein was expressed at each developmental stage shown 
in Figure 3.9. This result suggests that the Aqp1 proteins expressed in the presumptive 
corneal endothelial cells at E15.5 and mature corneal endothelial cells at P13 have 
undergone post-translational modification and have been translocated from the golgi 
complex to post-golgi compartments.  
 
Densitometry was performed on the western blot images to quantitate the band intensity 
which is indicative of the protein expression. Other members of the laboratory attempted to 
use Gapdh as a reference protein.  However, Gapdh showed variation in expression 
between the different cell lines and perhaps is not suitable in the developmental context. 
Therefore, Ponceau S staining was performed in this study to detect total protein on the 
membrane.   
 
 
Figure 3.10: Densitometric analysis of Zo1 protein expression relative to the total protein 
extracted. Expression values are normalised to E12.5 which is set at 1. Values are presented 




























Although not significant, Zo1 protein levels decrease from E12.5 to E15.5. Zo1 protein 
expression then increases again at P13 (Figure 3.10).  
 
  
Figure 3.11: Densitometric analysis of glycosylated and unglycosylated Aqp1 protein 
expression relative to the total protein extracted. Expression values are normalised to E12.5 
which is set at 1. Values are presented as the mean ± SEM (n=3). 
 
Glycosylated Aqp1 protein expression levels decrease gradually from E12.5 to P13. 
Unglycosylated Aqp1 protein was only expressed at E12.5 and E13.5, and increased at 
E13.5 compared to E12.5 (Figure 3.11).  
 
3.3.2 Protein localisation patterns of Zo1 and Aqp1 determined by 
immunocytochemistry    
Confocal microscopy was performed to evaluate the protein localisation patterns of Zo1 































well as hanging drop culture, mimicking the 3D environment in which corneal endothelial 
development takes place. Settings were kept identical to allow for comparison between the 
images. Images for the no-primary and no-secondary antibody controls are shown in 
Appendix 2.  
 
 
Figure 3.12: 63x confocal microscopy image of monolayer cultures for Zo1. A) DAPI 
stained cells B) Zo1 stained cells C) Merged DAPI and Zo1 image. PN= perinuclear 
localisation of Zo1. Scale bar is 20 µm.  
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Zo1 protein localisation was difficult to detect in monolayer culture in this model, despite 
the repeated attempts to optimise the staining protocol using this Zo1 antibody. Dilution 
series and time series experiments were conducted in which different concentrations of the 
antibody and different incubation times were assessed for optimal Zo1 staining. Monolayer 
cultures were also grown in serum free media to assess whether protein factors in the serum 
affected Zo1 expression (Appendix 3b). However, despite this, very little Zo1 staining was 





Figure 3.13: 25x confocal microscopy image of hanging drop cultures for Zo1. A) DAPI 
stained cells B) Zo1 stained cells C) Merged DAPI and Zo1 image. CM= membrane 
localisation of Zo1. Scale bar is 50 µm.  
 
Zo1 staining was not detected at E12.5 in this model. A perinuclear lattice of Zo1 staining 
was observed in the cell membrane from E13.5 to P13 in this model of corneal endothelial 
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development. Although faint, it appears that Zo1 has localised to the cell membrane at 
E13.5 and E15.5. The images show high expression of Zo1 at P13 (Figure 3.13).   
 
 
Figure 3.14: 63x confocal microscopy image of monolayer cultures for Aqp1. A) DAPI 
stained cells B) Aqp1 stained cells C) Merged DAPI and Aqp1 image. The antibody 
recognises both glycosylated and unglycosylated protein. PN= perinuclear localisation of 
Aqp1. CM= membrane localisation of Aqp1. Scale bar is 20 µm. 
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Aqp1 was homogenously distributed in the cytoplasm in POM cells at E12.5 and E13.5. 
Although there was still cytoplasmic expression, perinuclear Aqp1 staining was distinct in 
differentiated corneal endothelial cells at E15.5. Some Aqp1 has also localized to the 
membrane at E15.5. Although faint, at P13, Aqp1 has localized to the membrane where 






Figure 3.15: 25x confocal microscopy image of hanging drop cultures for Aqp1. A) DAPI 
stained cells B) Aqp1 stained cells C) Merged DAPI and Aqp1 image. CM= membrane 
localisation of Aqp1. Scale bar is 50 µm.  
 
A perinuclear lattice of Aqp1 staining was observed from E12.5 to P13 in this model of 
corneal endothelial development. Aqp1 localisation in the membrane was more distinct at 
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E13.5 compared to E12.5, and more distinct at P13 compared to E15.5. The images show 
high expression levels of Aqp1 at E13.5 (Figure 3.15).  
 
3.4 Establishment of a stable Foxc1 knockdown cell line 
Despite numerous attempts to sub-clone the siRNA insert into the expression vector, this 
was not achieved within the time frame of this research project. However, an immense 
amount of work and troubleshooting was performed, details have been supplied in 





The mammalian eye is a specialised organ whose function depends on co-ordinated 
interactions between the structures of the anterior and posterior segments. Embryonic 
development of the anterior segment of the eye is a multifaceted process that requires 
precise molecular cues. Disrupted morphogenesis of the anterior segment initiates a cascade 
of developmental disorders that can result in anterior segment dysgenesis (ASD) (Ito and 
Walter, 2014). Axenfeld-Rieger Syndrome (ARS) and Peters Anomaly are the two most 
prevalent and well-studied developmental eye disorders that are associated with abnormal 
development of the anterior segment. Both conditions are characterized by overlapping 
phenotypes that include iris hypoplasia, corectopia (iris rupture), prominent Schwalbe’s line 
or iridocorneal synechiae in which the cornea fails to separate from the lens or the iris. The 
most important feature of these phenotypes is the increased risk of developing glaucoma 
which is the second leading cause of blindness worldwide (Kidson et al., 1999, Alward, 
2000, Reneker et al., 2000, Nishimura et al., 2001).  
 
 
Figure 4.1: A patient presenting with a severe form of ARS with iris hypoplasia, peripheral 





The cornea, a layered structure, is an integral component of the anterior segment of the eye. 
Bullous Keratoplasty and Fuchs’ endothelial dystrophy are two common clinical conditions 
that involve corneal endothelial damage and progressive corneal edema. They are the two 
leading causes of corneal transplant surgery (keratoplasty) in the United States (Macnamara 
et al., 2004, Besharse et al., 2010). Other disorders closely related to Fuchs’ dystrophy 
include posterior polymorphous dystrophy (PPMD) and congenital hereditary endothelial 
dystrophy (CHED). Fuch’s dystrophy is characterized by a thinning of corneal endothelial 
cells, while CHED is characterized by a loss of endothelial cells (Besharse et al., 2010).  
 
Keratoplasty is currently the only option available to treat corneal dysfunction caused by 
aging (Peh et al., 2011), genetic disorders (Liu et al., 2010), intraocular surgery, laser 
procedures (Fan et al., 2011), trauma/injury or disease (Du et al., 2009, Makgotloe and 
Carmichael, 2009, Schwartzkopff et al., 2010). Cadaver tissue is currently the only source 
of donor graft tissue that can be used to surgically repair damaged corneas (Peh et al., 
2011). Although keratoplasty has a high success rate (Schwartzkopff et al., 2010), corneal 
donations have decreased worldwide (Meyer, 2007, Liu et al., 2010, Peh et al., 2011). 
Furthermore, modern medicine has facilitated an increase in the ageing population and 
general life expectancy of the population (Araujo Silva et al., 2011). Consequently, the 
demand for corneal transplants exceeds the number of corneal donations (Peh et al., 2011).  
 
Although considerable research has been directed towards developing alternate donor graft 
tissue through tissue engineering, producing functional corneal endothelial tissue remains a 
formidable task as these cells do not proliferate in vivo (Peh et al., 2011). 
 
Current literature, as reviewed in chapter 1, provides compelling evidence for the 
importance of the functional genes Zo1, Aqp1 and Slc4a4 in corneal endothelial physiology. 
However, there is a major gap in the literature with regards to the expression patterns of 
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these genes throughout development. These studies generally characterise the expression of 
these functional genes in adult corneal endothelium and assess the effects of gene 
knockdown. Whilst this information is undoubtedly valuable, we need to further our 
understanding of the developmental expression patterns of these functional genes in order 
to produce viable tissue alternatives. Comprehensive studies mapping gene expression 
patterns at key stages in corneal endothelial development will provide the baseline values 
needed for further studies such as stem cell based tissue engineering. As we are unable to 
access developing corneas in vivo, the best alternative is to use an in vitro model of corneal 
endothelial development.  
 
4.1 Establishing an in vitro model of murine corneal endothelial development  
In this study, we created an in vitro model of murine corneal endothelial development by 
immortalising endothelial cells at significant stages in corneal endothelial morphogenesis. 
Presumptive corneal endothelial cell were immortalised from E14.5 and E15.5 wild-type 
mouse embryos and mature endothelial cells were immortalised from P13 wild-type mouse 
pups.  
 
These immortalised cell lines, together with already established cell lines at earlier stages in 
corneal endothelial development (E12.5 and E13.5), were used to map the expression 
patterns of three functional genes associated with corneal endothelial function, Zo1, Aqp1 
and Slc4a4. 
 
POM cells differentiate into both the corneal endothelium and the stroma during embryonic 
eye development (Cvekl and Tamm, 2004, Gage et al., 2005). The cell lines express all the 
tested corneal endothelial markers, however, none of the cell lines exhibit stromal markers 
(unpublished data from another member of the laboratory), possibly because they have 
been cultured predominantly in monolayer. The cells may have exhibited stromal markers 
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if they were grown on a matrix that mimics the stroma, consequently altering the results 
obtained in this study. This could be taken into account in future developmental studies.    
 
To determine whether the procedure used to immortalise the cell lines had effects on the 
endogenous gene expression patterns of these genes, quantitative real-time PCR (qPCR) 
was performed on non-immortalised cells at E14.5, E15.5 and P13. Aqp1 expression was 
used as a representative of all the cell lines. The gene expression pattern of Aqp1 in non-
immortalised cells was similar to immortalised cells at the various stages (Figure 3.5). 
Therefore, the procedure used to immortalise the cell lines did not affect the gene 
expression pattern of Aqp1 (Figure 3.7) at low passages used in this study. Previously we 
showed that immortalisation did not affect the endogenous expression of Foxc1 at E12.5 
and E13.5 (Silla et al., 2014).   
 
Cell culture and in vitro expansion is known to affect gene expression patterns, and this was 
shown for Slc4 genes (Shei et al., 2013). For this reason, caution was taken in the 
experimental design of this study to ensure that the biological replicates of each cell line 
were at the same passage for all qPCR and western blot analyses.  
 
4.2 Characterising intercellular junctions present in the corneal endothelium by 
assessing Zo1 gene and protein expression at various stages of development  
Intercellular junctions, namely gap, adherens and tight junctions, play an important role in 
maintaining cell-cell adhesion and communication between adjacent cells. Tight junctions 
play a particularly important role in cellular communication by controlling the movement 
of small molecules across apical and basolateral compartments of the plasma membranes 
between adjacent cells, thereby controlling the permeability of the para-cellular pathway 
(Ying-Ting et al., 2008, Kojima et al., 2009).  
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Zo1 was the first tight junction protein studied (Stevenson et al., 1986). It is a selectively 
semipermeable protein that acts as a scaffold to which other intercellular junctions bind. 
Claudin, occludin and JAM proteins bind to Zo1 and collectively form the structural 
components of the tight junctions that join adjacent cells (Stevenson et al., 1986, Sugrue 
and Zieske, 1997, Ban et al., 2003, Kojima et al., 2009). 
 
Zo1 expression has been observed very early in development. A study by Wang et al. 
(2008) analysed the effects of Zo1 knockdown in the process of morula to blastocyst 
formation in the mouse and found that Zo1 expression is required for initiating blastocyst 
formation from the morula (Wang et al., 2008). These results support the importance of 
Zo1 expression during all stages of development. Zo1 expression is particularly important 
during wound healing (Cao et al., 2002, Stepp et al., 2002, Lu et al., 2012).    
   
The corneal endothelium is a monolayer of cells joined by tight junctions that form a 
barrier between the stroma and aqueous humor in the anterior chamber of the eye. The 
ability of corneal endothelial cells to maintain a tightly packed monolayer is imperative to 
its function. Without tight junctions, the monolayer would be disrupted and its function 
would be impaired. Fluid would flow into the stroma unrestricted and stromal hydration 
would increase, thus causing loss of stromal proteoglycans, disorder of collagen fibrils and 
subsequent loss of transparency (Hemmavanh et al., 2013). Given its role in tight junction 
formation, Zo1 is therefore a predominant function related marker of tight junction 
formation in corneal endothelial cells.   
 
qPCR and western blot analysis showed that Zo1 was expressed at both mRNA and protein 
level and that Zo1 gene expression patterns correlated with protein expression patterns. Zo1 
gene expression was progressively down-regulated from E12.5, when the corneal 
endothelium begins to differentiate, to E15.5 when the corneal endothelium is completely 
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differentiated (Figure 3.4). Postnatal corneal endothelial cells (at P13) express significantly 
higher levels of Zo1 mRNA relative to presumptive corneal endothelium at E15.5 (Figure 
3.4).  
 
Western blot analysis demonstrated a single protein band (~220 kDa) at each stage of 
development that represents Zo1 expression (Figure 3.8). Densitometric results demonstrate 
that the protein expression pattern obtained for Zo1 from E12.5 to P13 (p>0.05) (Figure 
3.10) is similar to the gene expression pattern in this study (Figure 3.4). The results show 
that the up-regulation of this tight junction protein, at both mRNA and protein level, 
coincides with corneal endothelial maturity at P13. The mature corneal endothelium at P13 
is a fully functional monolayer which explains the requirement for greater levels of this 
tight junction protein when compared to earlier developmental stages.  
It is important to note that a sonication step was not included during the protein extraction 
protocol. This may account for a possible loss of membrane-bound proteins. Although a 
sonication step was not included in this study, it should be taken into account in future 
studies that aim to analyse the expression patterns of membrane bound proteins such as 
Zo1.    
 
Confocal microscopy was performed to evaluate the protein localisation patterns of Zo1 at 
E12.5, E13.5, E15.5 and P13 in monolayer culture as well as hanging drop culture, 
mimicking the 3D environment in which corneal endothelial development takes place. Zo1 
protein localisation was difficult to detect in monolayer culture. Although faint, some 
perinuclear Zo1 staining was detected in monolayer culture at E13.5, E15.5 and P13 
(Figure 3.12). In hanging drop culture, Zo1 was clearly localised to the cell membrane at 
E13.5, E15.5 and P13 in this model of corneal endothelial development. A perinuclear 
lattice of Zo1 staining was detected at these stages, with high expression of Zo1 at P13 
(Figure 3.13). The presence of continuous Zo1 protein staining was detected at the cell 
92 
 
borders between adjacent cells in hanging drop culture, suggesting the ability of these cells 
to form an intact monolayer. 
 
Endothelial cell-cell junctions, extensively reviewed by Bazzoni and Dejana (2004), are 
continuously translocated between intracellular compartments and the cell membrane, but 
the underlying mechanisms that drive this translocation are not well characterised. Zo1 
localisation is therefore a dynamic process whereby Zo1 is translocated between the 
cytoplasm and nucleus (Bauer et al., 2010). The correlation between Zo1 protein 
expression and culture confluency in endothelial cells was established by Li and Poznansky 
(1990) who found that Zo1 was only expressed in the cell membranes when the cells were 
in direct contact with each other. Zo1 has been shown to localise to the nucleus on sub-
confluent epithelial cells before tight junction maturation (Bauer et al., 2010). Therefore 
Zo1 nuclear localisation is more likely to relate to the extent or maturity of cell to cell 
contacts.  
 
Although confocal analysis did not detect distinct Zo1 localisation in monolayer culture, it 
did detect Zo1 in hanging drop culture where the cells are in 3D contact with one another. 
The mRNA and protein for qPCR and western blot analysis was harvested from cells in 
monolayer culture. Therefore, gene and protein expression patterns of cells grown in 
hanging drop culture may yield different Zo1 expression patterns compared to the Zo1 
expression patterns presented in this study. Clearly, the different methods have different 
levels of detection. It is therefore very clear that culturing the cells in a more 3D 
environment has an effect on Zo1 expression and localisation. It would be interesting to 
analyse Zo1 protein and mRNA in the hanging drops but the tiny nature of the drops does 
not allow for this. It is possible that cell to cell contact in a 3D environment configuration is 




Calcium ions are necessary for the formation of the protein complex associated with tight 
junction formation (between adherens and tight junction proteins) (Ju et al., 2012, Silla et 
al., 2014). It is possible that the calcium in the medium may have been a factor that resulted 
in faint Zo1 staining in monolayer culture. It is important to note that the cells were also 
grown in serum-free media in monolayer culture in an attempt to optimise the protocol to 
detect Zo1 expression. However, there was no visible difference in Zo1 staining in the cells 
grown in serum-free media (images not shown). 
 
Zo1 is a phosphoprotein  (Sugrue and Zieske, 1997, Ban et al., 2003), and therefore post-
translational phosphorylation may play a role in its cellular localisation. Zo1 expression is 
regulated by phosphorylation, but it is unknown whether phosphorylation is required for 
translocation to a post-golgi compartment such as the cell membrane. Sugrue and Zieske 
(1997) suggested that Zo1 expression in the cell membrane is regulated by reversible 
phosphorylation.  Ulluwishewa et al. (2011) reported that reduced Zo1 phosphorylation 
was associated with increased transendothelial electrical resistance (a measure of tight 
junction resistance) in canine kidney cells type 1 (MDCK-1) epithelial cells in monolayer 
culture. Zo1 phosphorylation must therefore be regulated for expression and function in the 
cell membrane. Zo1 localisation in this model, shown in the confocal images, may have 
been affected by the phosphorylation state of the cells at these developmental stages. 
 
Corneal endothelial cells undergo mesenchyme-epithelial transition (MET) during early 
stages of development (i.e. E12.5 to E15.5) whereby the cells change from a motile 
phenotype to an ordered cohesive structure. MET is characterised by a gain of cell 
junctions and up-regulation of the factors that promote cell-cell adhesion (Thiery, 2003, 
Baum et al., 2008, Silla et al., 2014). The progressive down-regulation of Zo1 at these 
stages is therefore an unexpected result. A possible explanation may be that the cells 
generate a large reserve of Zo1 mRNA and proteins at the proliferative stages of 
development (i.e. E12.5) and no longer need to generate large amounts of Zo1 until the 
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endothelial layer is completely functional at P13. The statistically significant up-regulation 
from E15.5 to P13 is suggestive of a maturation of the barrier function from the 
differentiated state at E15.5 to the more mature functional state at P13.       
Confocal microscopy of mouse corneal tissue at P4, P14 and P30 show that Zo1 expression 
is diffuse and localized to both the apical and basolateral membranes of the corneal 




Figure 4.2: Endothelial junction maturation in WT mice at P14 and P30. Red staining 
represents Zo1 expression in the corneal endothelium of WT mouse corneas. (A) Zo1 is 
expressed in the apical and lateral corneal endothelial membrane at P14. (B, C) Zo1 
expression becomes localised to the lateral membrane at P30. The yellow box in (B) 




Hemmavanh et al. (2012) demonstrate that Zo1 expression becomes more regularly spaced 
as the endothelium matures at P30 (Hemmavanh et al., 2013). It is clear from these images 
that tight junctions mature over time. The tight junctions in the endothelium at P13 are, 
therefore, immature relative to P30.  
 
Kidson et al. (1999) examined normal and mutant (Foxc1-/-) whole corneas under the 
confocal microscope for the presence of Zo1 protein. The results of this study concluded 
that the mutant cornea lacked the presence of continuous bands of tight junctions that are 
present between the posterior endothelial cells in normal corneas. Occasional Zo1 staining 
was attributed to the stromal layer, whose cells are able to synthesize some Zo1, but fail to 
form the continuous bands that are required for to form a monolayer (Kidson et al., 1999). 
 
Although the importance of tight junctions is well-known, the regulatory mechanisms that 
underlie tight junction formation are not completely understood (Ramachandran and 
Srinivas, 2010). Corneal endothelial cells contain a dense band of actin cytoskeleton which 
is referred to as the perijunctional actomyosin ring (PAMR). Tight junctions bind to the 
PAMR through tight junction proteins, such as Zo1, facilitating cell signaling, particularly 
signaling that involves the Rho family of small GTPases (Ramachandran and Srinivas, 
2010). Zo1 is therefore required to regulate the connection between the PAMR of adjacent 
cells and tight junction complexes. The loss of corneal endothelial cells and consequent 
edema through ageing, disease or trauma is characterised by the loss of tight junctions. 
Understanding the regulatory mechanisms that underlie tight junction formation may 
provide the insight required to develop pharmacological strategies against corneal 




The cornea, located in the anterior segment of the eye, is exposed to various environmental 
factors including physical and chemical injuries, and microbial infections. The corneal 
epithelium is the outermost layer of the cornea and is therefore the first layer to be exposed 
to the external environment. Given its position, the corneal epithelium has a remarkable 
ability to continuously undergo self-renewal and wound healing. Epithelial cells undergo a 
remarkable rate of proliferation; migration and differentiation to maintain renewal and 
wound healing. Essentially epithelial cells at the wound edge begin to migrate to cover the 
denuded area. Once the epithelial layer has been restored at the wound area, the cells 
differentiate to form tight junctions and re-establish the barrier function  (Lu et al., 2012). 
Although the molecular cues that direct wound healing are beyond the scope of this study, 
the functional importance of Zo1 in other corneal layers warrants mention as the barrier 
function of the corneal epithelium and endothelium is critical for corneal integrity and 
normal vision (Lu et al., 2012).  
 
Adherens junctions maintain cell-cell contact in addition to tight junctions. Cadherens, 
which are essentially specific adherens junctions, are calcium ion (Ca2+) dependent proteins 
that facilitate cell-cell adhesion between adjacent cells (Reneker et al., 2000). N-cadherin 
(N-cad) is widely expressed in many tissues and is often used as a marker of cell 
differentiation. N-cad expression coincides with corneal endothelial differentiation (Ju et 
al., 2012, Silla et al., 2014). Owing to the fact that N-cad is widely expressed in many cell 
types and that Zo1 is also expressed in stromal cells (Kidson et al., 1999), relying on one 
cell contact marker could lead to misleading results. Therefore, the use of multiple 
differentiation and function-related protein markers can strengthen the results of future 
studies that aim to characterise corneal endothelial cells (Ju et al., 2012). Both N-cad and 
Zo1, among other markers, were used to identify the induction of corneal endothelial cells 
from neural crest cells in a study conducted Ju et al. (2012). Future studies could include 




The expression of Zo1 mRNA and protein in this study is suggestive of a mature functional 
endothelium that is able to maintain corneal deturgescence, thus adding to the value of this 
in vitro model of corneal endothelial development.   
4.3 Characterising the pump function of the corneal endothelium  
Corneal deturgescence is actively maintained by the pump function of the corneal 
endothelium. With the exception of oxygen, all the nutrients required for corneal 
transparency are transported from the aqueous humor through the corneal endothelium into 
the corneal stroma and epithelium. The accepted pump-leak hypothesis (Maurice, 1981) 
states that there is a fluid balance between the stroma and the aqueous humor, where fluid 
is ‘pumped’ out of the stroma into the aqueous humor while fluid ‘leaks’ into the stroma 
from the aqueous humor. The corneal stroma has a high concentration of 
glycosaminoglycans that create an osmotic driving force for the accumulation of fluid in 
the stroma. The corneal endothelium is thus responsible for actively pumping fluid out of 
the stroma into the aqueous humor, to essentially counteract the continuous leak of fluid 
into the stroma. The constant pump-leak action across the corneal endothelium is 
responsible for maintaining a relatively dehydrated stroma, a requirement for corneal 
transparency (Bonanno, 2012). The corneal endothelium relies on various transporters and 
channels to maintain its pump-leak function. 
 
4.3.1 Characterising the water channels present in corneal endothelial cells by 
assessing Aqp1 gene and protein expression at various stages of development  
Aqp1 is a water channel protein that mediates transcellular fluid transport across plasma 
membranes of tissues that depend on water/fluid transport. 
 
AQPs are ubiquitously expressed in extra-ocular tissues involved in fluid transport. Mice 
lacking Aqp1 manifest defective urinary-concentrating and lung water permeability 
(Thiagarajah and Verkman, 2002). Mice lacking Aqp5 manifest defective fluid secretion by 
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salivary and airway glands, and reduced alveolar water permeability in the lungs 
(Thiagarajah and Verkman, 2002).  
 
Although the physiology of AQP-mediated water transport is not fully understood, progress 
has been made in understanding the intracellular transport of AQP proteins. Hendriks et al. 
(2003) studied Aqp2 protein expression in canine kidney cells type 1 (MDCK-1) cells and 
reported that N-linked glycosylation is important for its transport from the golgi-complex to 
post golgi-compartments such as the plasma membrane. They reported that both 
glycosylated and unglycosylated Aqp2 proteins are stable, indicating that glycosylation is 
not required for stability of the wild-type protein.  Both glycosylated and unglycosylated 
Aqp2 proteins yielded similar water permeability which demonstrates that glycosylation is 
not required for the ability of the proteins to act as functional water channels. To determine 
if glycosylation is N-linked, they removed the N-linked glycosylation consensus site and 
reported that this removal did not affect the expression of the unglycosylated protein but 
did diminish the expression of the glycosylated protein. Aqp2 glycosylation is therefore N-
linked. Their results also demonstrated that a mutant Aqp2 protein that did not contain an 
N-linked consensus site was not present on the cell surface, which suggests that the mutant 
was unable to undergo glycosylation and was therefore retained on the endoplasmic 
reticulum or another intracellular compartment. Overall the results of this study 
demonstrate that glycosylation is required for Aqp2 cell surface expression and that the 
absence of glycosylation induces intracellular retention (Hendriks et al., 2004). To the best 
of my knowledge this is the most comprehensive study on Aqp glycosylation published to 
date. Given that Aqp1 and Aqp2 have the same substoichiometric glycosylation (Smith et 
al., 1994, Hendriks et al., 2004), the structure and function of these two homologs are 
comparable.    
    
qPCR and western blot analysis showed that Aqp1 was expressed at both mRNA and 
protein level.  Unlike Zo1, Aqp1 gene expression patterns in this study do not correlate with 
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protein expression patterns. Aqp1 gene expression was significantly up-regulated from 
E12.5, when the corneal endothelium begins to differentiate, to E13.5 as differentiation 
continues (Figure 3.5). Aqp1 gene expression was then significantly down-regulated from 
E13.5 to E14.5 when the corneal endothelium is almost completely differentiated, followed 
by an up-regulation at E15.5 when the corneal endothelium is completely differentiated 
(Figure 3.5). Postnatal corneal endothelial cells (at P13) express significantly lower levels 
of Aqp1 mRNA relative to presumptive corneal endothelium at E15.5 (Figure 3.5). 
Interestingly, Aqp1 mRNA levels were the highest at E13.5 when the corneal endothelium 
is still differentiating. A similar result was observed for Zo1 mRNA expression, whereby 
the endothelial cells appear to be producing more Zo1 and Aqp1 mRNA transcripts at the 
earlier proliferative stages in development. Unlike Zo1 expression at P13, Aqp1 gene 
expression is significantly reduced at P13 which suggests that the cells do not require 
additional mRNA transcripts at this stage of development. Although not statistically 
significant, the up-regulation of Aqp1 mRNA transcripts at E15.5 may have biological 
significance by serving as a large enough reserve to sustain the water channels at P13 when 
the corneal endothelium is completely functional.    
 
Western blot analysis demonstrated two protein bands at each stage of development that 
represent Aqp1 expression (~35kDa for glycosylated Aqp1 and ~28kDa for unglycosylated 
Aqp1) (Figure 3.9). Unglycosylated Aqp1 was only detected at the early proliferative stages 
of development (E12.5 and E13.5). Glycosylated Aqp1 was detected at each stage of 
development (Figure 3.9). This suggests that Aqp1 proteins at E15.5, when the corneal 
endothelium is completely differentiated, have undergone post-translational modification 
and have been translocated from the golgi-complex to the cell surface. A strict experimental 
design, whereby RNA and protein were extracted from the cells at the same passage for 
each biological replicate, ensures that the results are comparable. Consequently, this result 




Aqp1 protein expression in the anterior epithelial cells of the mouse lens also show a band 
at ~28 kDa corresponding to the unglycosylated Aqp1 protein and a band at ~34kDa 
corresponding to the glycosylated Aqp1 protein (Ruiz-Ederra and Verkman, 2006).  
Densitometric results demonstrated that the protein expression pattern obtained for Aqp1 
from E12.5 to P13 (p>0.05) (Figure 3.11) does not follow the gene expression pattern in 
this study (Figure 3.5).  The results show that unglycosylated Aqp1 was up-regulated from 
E12.5 to E13.5, although not statistically significantly. Glycosylated Aqp1 expression was 
slightly down-regulated from E12.5 to E13.5, but remained relatively constant thereafter at 
both E15.5 and P13 (p>0.05). This result suggests that protein expression of this water 
channel protein is stable and that expression levels at E15.5 is presumably adequate for its 
function at P13 when the pump function of the corneal endothelium is fully functional. 
Clearly, gene expression analyses do not distinguish between these two forms of post-
translational modifications. Elevated Aqp1 mRNA transcript levels at E13.5, shown in 
Figure 3.5, therefore represent both glycosylated and unglycosylated forms of this protein. 
 
Aqp1 is the most abundantly expressed AQP isoform in humans, rats and mice. Its 
expression has been documented in cardiac tissue, particularly in endothelial and vascular 
muscle cells that are key regulators of transcellular fluid transport (Montiel et al., 2014). 
Montiel et al. (2013) reported several Aqp1 protein bands from total protein extracts of the 
heart, aorta and mesenteric artery. These bands were attributed to the differential migration 
of glycosylated AQP proteins. They reported that Aqp1 deletion affected the expression of 
other aquaporin isoforms, for example, over-expression of Aqp4, Aqp7, and Aqp8 was 
detected in Aqp1 null mice. Given the wide expression of all the AQP isoforms in ocular 
tissue (reviewed in Table 1), it would be interesting to characterise the effects of Aqp1 




Confocal microscopy demonstrated that Aqp1 expression was homogenously distributed in 
POM cells at E12.5 and E13.5 in monolayer culture. Perinuclear staining was distinct at 
E15.5 when the corneal endothelial cells are fully differentiated. Some Aqp1 was also 
localised to the cell membrane at E15.5. At P13, Aqp1 has localised to the cell membrane 
in monolayer culture (Figure 3.14). In hanging drop culture, a distinct perinuclear lattice of 
Aqp1 staining was observed from E12.5 to P13 in this model of corneal endothelial 
development. The images show Aqp1 localisation at the cell membrane was more distinct 
at E13.5 and P13 (Figure 3.15). A polyclonal Aqp1 antibody, that detects both glycosylated 
and unglycosylated Aqp1 proteins, was used in this study. As shown in Figure 3.11, 
unglycosylated Aqp1 levels are elevated at E13.5. This result may account for the intense 
Aqp1 staining detected in hanging drop culture at E13.5 (Figure 3.15).  
 
Macnamara et al. (2004) studied Aqp1 expression in human and mouse corneal endothelial 
dysfunction. Tissue samples were obtained from 18 patients undergoing corneal 
transplantation surgery. Of these, 4 patients had Fuch’s dystrophy, 5 had Bullous 
Keratopathy (BK), 1 had a corneal graft failure due to endothelial decompensation, 2 had 
keratoconus (non-corneal endothelial disease) and 6 had corneal scarring from trauma or 
infection (non-corneal endothelial trauma). Additionally, 3 normal corneas from donor 
tissue were analysed. A mouse model of corneal injury was induced with injection of sterile 
hot water in the anterior chamber of the eye in wild-type mice. The results demonstrated 
that Aqp1 expression was diminished in the human corneal tissue with corneal endothelial 
disease (i.e. Fuchs dystrophy, BK, graft endothelial failure) and in the animal model of 
corneal endothelial injury. Aqp1 expression was unchanged in human corneal tissue with 
non-corneal endothelial disease (i.e. keratoconus and corneal scarring). Although the results 
of this study provide compelling evidence of the importance of Aqp1 expression in corneal 
endothelial cells, it is not clear whether reduced Aqp1 expression is a cause or effect of 
corneal endothelial disease. Future studies are needed to determine the key regulators of 
AQPs and to determine if Aqp1 up-regulation in the corneal endothelium may facilitate 
rehabilitation of swollen and diseased corneas (Macnamara et al., 2004). A clinical 
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manifestation of these corneal endothelial diseases is chronic corneal edema, which 
essentially leads to loss of transparency and subsequent vision loss. The results of future 
‘cause and effect’ studies of disease target genes such as Aqp1 may provide effective 
treatment strategies aimed at managing these pathological diseases affecting the eye.  
4.3.2 Characterising the ion pumps present in corneal endothelial cells by assessing 
Slc4a4 gene expression at various stages of development  
Slc4a4 is an ion pump, present in the basolateral membrane of corneal endothelial cells, 
which transports cellular bicarbonate ions across plasma membranes. Bicarbonate ions play 
an important role in the pump function of corneal endothelial cells. Carbonic anhydrase 
(enzyme that converts carbon dioxide and water to bicarbonate ions) inhibitors prevent the 
process of fluid reabsorption across the endothelium, thus reiterating the role of bicarbonate 
ions in corneal deturgescence (Bonanno, 2012, Suzuki et al., 2012).  
 
A recent study by Shei et al. (2013) characterised the relative expression levels of all the 
solute carrier 4 family members in adult murine corneal endothelial cells. The study also 
analysed the effects of cell culture and in vitro expansion on baseline expression levels by 
comparing the gene expression levels at different passages (passage 2 and 7). The results of 
the study demonstrate that cell culture does affect the expression levels of Slc4 genes. 
Mesenchymal markers such as Collal were detected at the later passage, which suggests 
that the phenotype of the endothelial cells were changing. Further studies could include a 
mesenchymal marker as a check point to determine if the endothelial cells in culture have 
undergone phenotypic changes as these changes would affect gene expression (Shei et al., 
2013).  
 
qPCR analysis showed that Slc4a4 gene expression was progressively up-regulated from 
E12.5, when the corneal endothelium begins to differentiate, to E14.5 when the corneal 
endothelium is almost completely differentiated (Figure 3.6). Interestingly, Slc4a4 gene 
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expression is down-regulated from E14.5 to E15.5 when the corneal endothelium is 
completely differentiated. This result suggests that the ion pump function may not yet fully 
be established at this stage of development or that sufficient mRNA is present to produce 
protein. Postnatal corneal endothelial cells (at P13) express significantly higher levels of 
Slc4a4 mRNA relative to presumptive corneal endothelium at E15.5 (Figure 3.6). Slc4a4 is 
highly expressed at P13, indicative of an established pump function at this stage of 
development. The significant up-regulation of this ion pump, at mRNA level, coincides 
with corneal endothelial maturity at P13. The mature corneal endothelium is an active 
functional monolayer which explains the requirement for greater levels of this ion pump 
protein when compared to earlier developmental stages. A limitation of this study is the 
lack of Slc4a4 protein expression data, which could not be determined due to the lack of a 
commercially available antibody specific for mouse Slc4a4.  
 
Among the Slc4 members assessed by Shei et al. (2013), Slc4a11 was the most highly 
expressed isoform in corneal endothelial cells, followed by Slc4a4, Slc4a2 and Slc4a7 (Shei 
et al., 2013). A limitation of the Shei et al. (2013) study is that gene expression was only 
assessed in adult corneal endothelial cells. The results of the current study provide a 
developmental pattern, which given for the other highly expressed Slc4 members, could 
provide valuable insight into corneal dystrophies related to these members. Several 
members of the Slc4 family have been linked to ocular diseases, particularly corneal 
dystrophies. Slc4a11 mutations are associated with corneal dystrophies including late-onset 
CHED. A study by Chen et al. (2013) analysed several novel molecular markers in human 
fetal and adult corneal endothelial cells. They identified 284 signature genes that are highly 
expressed in human corneal endothelial cells. Among these genes, they identified Slc4a11 
as one of the top-ranking genes, thus supporting the use of Slc4 members as markers of 
function in corneal endothelial cells. Slc4a4 and Slc4a11 are both well-established disease 
target genes which is indicative of their functional significance in corneal endothelial 
physiology (Chen et al., 2013, Shei et al., 2013).  Future studies could include Slc4a11 
throughout development to contribute to the mapping of disease target genes associated 
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with the development of the corneal endothelium. Although the precise function of each 
Slc4 member is unknown, their wide expression in corneal endothelial cells and the known 
importance of bicarbonate ions in the pump function of corneal endothelial cells, strongly 
suggests that they are of great importance in corneal endothelial physiology. 
4.4 Conclusion and future considerations 
Optimal functioning of the corneal endothelium depends on cell features that include its 
cytoskeleton, signaling cascades and a host of regulatory membrane proteins (Fischbarg, 
1997). Failure of any of these elements could result in corneal endothelial decompensation, 
which is the most documented reason for corneal endothelial dysfunction. Endothelial 
decompensation occurs as surviving cells spread out over the denuded surface, essentially 
changing their shape and volume which alters their function (Fischbarg, 1997).  
 
The genes expressed in this model are associated with key corneal endothelial functions. 
The barrier function is well established at P13, which correlates well with the increased Zo1 
mRNA and protein expression in mature corneal endothelial cells. Aqp1 and Slc4a4, both 
part of the pump function of these cells, are differentially expressed throughout 
development.       
 
Cell junctions, water channels, ion pumps and transporters function together to drive ion-
coupled fluid absorption across the corneal endothelium. They essentially facilitate the 
pump-leak function of the corneal endothelium that is required to nourish the cornea and 
maintain corneal deturgescence and transparency required for vision.  The studies reviewed 
in this chapter have highlighted the importance of these functional genes in corneal 
physiology. Developmental gene and protein expression patterns of these genes will 
provide the baseline values needed to direct stem cells into a corneal endothelial phenotype. 
Stem cell therapy has gained the attention of research groups worldwide. Takahashi and 
Yamanaka 2006 demonstrated that pluripotent stem (iPS) cells can be generated from 
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fibroblast cultures by the addition of four inducing factors, Oct3/4, Sox2, c-Myc and Klf4 
(Takahashi and Yamanaka, 2006). In theory, iPS cells can then be directed to multiple 
phenotypes.  
 
The first corneal transplant was performed in 1905 and this technique is still the most 
effective way for treating corneal blindness. This alone highlights the need for innovative 
tissue regenerative techniques that could replace conventional transplantation. In 
developing countries, trachoma is the most cited cause of corneal blindness as hygiene and 
public health services are often inadequate (Liu et al., 2010). In South Africa, five regional 
eye banks harvest and supply corneal tissue to ophthalmic surgeons. The availability of 
corneal tissue in South Africa has declined due to various reasons. Government legislation 
has placed restrictions on access to information on the deceased. Before 2006, the South 
African Police Service forensic mortuaries allowed eye banks to access information on 
those who died of natural causes. Since then, the Department of Health has restricted access 
to this information owing to the confidential nature of this information. Consequently, eye 
banks have lost a source of information that could lead to potential donors. Furthermore, 
tissue from donors positive for HIV, hepatitis b or c is not safe for transplantation. 
Consequently, the number of suitable corneas that are safe for transplantation have declined 
drastically (Meyer, 2007, Makgotloe and Carmichael, 2009). These issues highlight the 
need for alternative graft tissue that can replace cadaver corneas for transplantation. 
 
Tissue engineered corneas, and perhaps personalised cell therapy, would supplement the 
supplies of donor corneal tissue. Furthermore, corneal equivalents could serve as a model 
for toxicological screening of drugs to treat corneal diseases (Ju et al., 2012). 
Comprehensive studies mapping gene and protein expression patterns at key stages in 
corneal endothelial development will provide extremely important information needed for 







1. The Minimum Information for Publication of Quantitative Real-time PCR 
Experiments (MIQE) 
MIQE is a set of guidelines that describes the information required for assessing qPCR 
experiments. They were established to promote consistency between all qPCR experiments 
to ensure that they are reliable and the results are reproducible. Reviewers rely on the 
MIQE guidelines to assess the validity of protocols used in publications based on the 
relevant experimental conditions and assay characteristics (Bustin et al., 2009). All qPCR 
experimental procedures used in this study were performed in accordance with the MIQE 
guidelines. 
 
1.1 Experimental design 
The relative expression of the target genes Zo1, Aqp1 and Slc4a4 in POM cells at E12.5 and 
E13.5, and presumptive corneal endothelium at E14.5 and E15.5, as well as mature corneal 
endothelium at P13 were evaluated by qPCR. RNA was extracted from the corneal 
endothelial cells cultured in a single T75 flask or 10 cm3dish. The cells were harvested by 
cell scraping as expression of adherens and tight junction mRNA transcripts is disrupted by 
trypsin-EDTA treatment (Ying-Ting et al., 2008). RNA was extracted from fully confluent 
flasks or dishes in which cell-cell contacts were visible under an inverted microscope. This 
ensured that tight junction mRNA transcripts were present. RNA integrity was evaluated by 
gel electrophoresis prior to cDNA synthesis. cDNA was synthesised using the GoScript™ 
Reverse Transcription System (Promega, USA). Two biological repeats were performed per 
developmental stage, with two technical repeats per biological and individual samples were 




All qPCR experiments and analyses were performed by myself at the research laboratory of 




1.2 Sample Information  
Cells were incubated at 37°C in a humidified Shel Lab 3553 CO2 incubator supplemented 
with 5% CO2. Stock cultures were maintained in T75 flasks containing 10 mL DMEM 
culture medium supplemented with 10% FBS and 0.5µg/mL pen/strep. Sub-cultures were 
maintained in 10 cm3 dishes containing 10 mL DMEM culture medium supplemented with 
10% FBS and 0.5µg/mL pen/strep. Cell growth was examined using an inverted Nikon 
TMS-F microscope and confluent cells were passaged by Trypsin-EDTA treatment as 
described in section 2.5 of the materials and methods. 
 
Stock cultures of each cell line were frozen down from confluent flasks or dishes. Stock 
cultures were stored in cryovials (Corning®) in 1 mL culture medium supplemented with 
10% dimethyl sulfoxide (DMSO). The cryovials were then flash dried in liquid nitrogen 
and stored in a liquid nitrogen dewar at -196°C. 
 
1.3 RNA extraction 
Total RNA was extracted using the QIAGEN RNeasy Kit according to the manufacturer’s 
instructions for purification of total RNA using spin technology as described in section 2.6 
of the materials and methods. The RNA samples were not DNase treated as this degrades 
the RNA. Instead, genomic DNA contamination was assessed by including a no-RT control 
and a NTC control (negative controls) in which the reverse transcriptase and template/RNA 
was replaced by nuclease free water respectively. Genomic DNA was also assessed by 
bleach agarose gel electrophoresis as described in Appendix 1.5 below. RNA samples were 
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aliquoted in volumes equivalent to 2 µg of RNA to ensure that each sample was only 
subjected to one freeze-thaw cycle. RNA aliquots were stored at -80°C. 
 
1.4 RNA quantification 
RNA samples were quantified using a Spectrophotometer ND1000 (NanoDrop 
technologies) using ND V3.5.2 software. Readings at A260 indicated the RNA concentration 
and the A260/280 ratio indicated the RNA purity (pure RNA has an A260/280   ratio between 1.8 
and 2.1) (Figure 5.1). 
 
 






1.5 RNA gel electrophoresis 
RNA integrity was assessed by gel electrophoresis. RNA samples were separated on a 1% 
bleach agarose gel as described in section 2.6.2 of the materials and methods. Gels were 
visualised and bands were detected under UV light in a Bio-Rad Chemidoc® XRS+ 
imaging system (Bio-rad, USA). Image Lab™ software version 2.0.1 (Bio-rad, USA) was 
used to analyse detected bands.  
 
The integrity of the RNA samples was confirmed by the presence of two bands of the 28S 
and 18S ribosomal subunits (Figure 3.2). 
 
1.6 Reverse transcription 
The GoScript™ Reverse Transcription System (Promega, USA) was used to synthesise 
complimentary DNA (cDNA). The kit includes a reverse transcriptase and specialised 
reagents for efficient synthesis of first-strand cDNA optimised for quantitative PCR 
analysis. The presence of the specialised RNase inhibitor reduces RNA degradation, thus 
increasing the overall yield and quality of the resultant cDNA. A standard concentration of 
2 µg RNA was used for cDNA synthesis in a Bio-Rad My cycler™ thermal cycler. The 
precise cDNA reactions and cycling conditions are described in section 2.7 of the materials 
and methods. 
 
1.7 Primer information 
Table 2.1 provided in section 2.7 of the materials and methods describe the primer sets for 
both target and reference genes used in this study. The primer sets, synthesised by Inqaba 
biotech, were diluted to 100 µM stock solutions according to the manufacturer’s 
instructions. Stock solutions were then diluted to a 10 µM working solution with nuclease 
free water. Primer stocks and working solutions were stored at -20°C.  
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1.7.1 The Basic Alignment Search Tool (BLAST) 
The Primer BLAST tool (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) was used to 
confirm that each primer set was specific to the target mRNA transcript in the Mus 
musculus genome available in the NCBI database (www.ncbi.nlm.nih.gov).  
 
 
Figure 5.2: In silico screen of the Zo1 primer BLAST against the Mus musculus genome. 




Figure 5.3: In silico screen of the Aqp1 primer BLAST against the Mus musculus genome. 
  
 




Figure 5.5: In silico screen of the Hprt primer BLAST against the Mus musculus genome. 
 
 
Figure 5.6: In silico screen of the β-actin primer BLAST against the Mus musculus genome.  
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The specificity of each primer set was also analysed by agarose gel electrophoresis of the 
PCR products (Figure 3.4) and qPCR products (Appendix 1.9). 
 
1.8 qPCR Protocol 
The qPCR protocol used in this study was sourced from Shei et al., 2013. SYBR® Green 
JumpStart™ Taq ReadyMix™ mastermix (Sigma-Aldrich®, USA) and SYBR® Select 
Master Mix (Applied Biosystems) were both used in this study. Although both reagents are 
florescent dyes that essentially work the same way, they do require slightly different 
reaction protocols and SYBR® Select Master Mix (Applied Biosystems) requires an 
additional activation temperature at 50°C for 2 minutes before the initial denaturation.   
 
1.8.1 SYBR® Green JumpStart™ Taq ReadyMix™ mastermix (Sigma-Aldrich®, 
USA) 
A 25 µl reaction consisted of 12.5 µl SYBR® Green JumpStart™ Taq ReadyMix™ 
mastermix (Sigma-Aldrich®, USA); 10.5 µl nuclease free water, 0.5 µl 10mM forward 
primer, 0.5 µl 10mM reverse primer and 1 µl cDNA. Reactions were transferred into a 
MicroAmp®Optical 96-well Reaction Plate (Applied Biosystems) in triplicate, which was 
gently centrifuged at 500 rpm for 1 minute at 4°C and placed in the Applied Biosystems 














Figure 5.7: The qPCR cycling protocol using SYBR® Green JumpStart™ Taq ReadyMix™ 





Figure 5.8: Amplification curves of βactin (A); Hprt (B) and Slc4a4 (C) amplified with 
SYBR® Green JumpStart™ Taq ReadyMix™ mastermix. 
 
1.8.2 SYBR® Select Master Mix (Applied Biosystems)  
A 20 µl reaction consisted of  10 µl SYBR select, 8 µl nuclease free water, 0.5 µl 10mM 
forward primer; 0.5 µl 10mM reverse primer and 1 µl cDNA. Reactions were transferred 
into a MicroAmp®Optical 96-well Reaction Plate (Applied Biosystems) in triplicate, which 
was gently centrifuged at 500 rpm for 1 minute at 4°C and placed in the Applied 
Biosystems 7500 Real-Time PCR System with HID Real-Time PCR Analysis Software 
version 1.2 




Figure 5.9: The qPCR cycling protocol using SYBR® Select Master Mix (Applied 
Biosystems), which requires an additional activation temperature at 50°C for 2 minutes 





Figure 5.10: Amplification curves of β-actin (A); Hprt (B) and SLC4a4 (C) amplified with 
SYBR select mastermix. 
 
The MicroAmp®Optical 96-well Reaction Plate (Applied Biosystems) used in this study is 
free of DNase, RNase and PCR inhibitors. Gilson Pipetman starter kit micropipettes 
(Gilson) were used to manually set up all qPCR reactions. Dedicated sterile TipOne 
beveled filter tips (Starlab) were used for reactions. All qPCR reagents and cDNA samples 
were kept on ice for the duration of the experiment. 
 
1.9 qPCR Melt analysis 
A melt curve analysis, generated by the HID Real-Time PCR Analysis software, provides 
another tool to determine the specificity of the primer sets and the protocol used in this 
study. The melt curve analysis ranged from 50°C to 90°C with 1°C increments and a plate 
read step was included for 5 seconds after each temperature change. A single peak in the 
A B C 
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sample (representing a single melting temperature) and multiple peaks in the NTC control 
of the same sample indicate a single amplicon for the primer set. The correct size of the 
amplicon was verified by gel electrophoresis (1% agarose gel as described in section 2.7.1 
of the materials and methods). 
 
 
Figure 5.11: Melt curve analysis and agarose gel verification of the Zo1 primer set. Zo1 




                   
Figure 5.12: Melt curve analysis and agarose gel verification of the Aqp1 primer set. Aqp1 








   
Figure 5.13: Melt curve analysis and agarose gel verification of the Slc4a4 primer set. 






Figure 5.14: Melt curve analysis and agarose gel verification of the Hprt primer set. Hprt 





    
Figure 5.15: Melt curve analysis and agarose gel verification of the β-actin primer set. Β-
actin qPCR melting temperature at 82.23°C and a product size of 104bp. 
 
 
1.10 Evaluation of qPCR reaction efficiency  
To accurately quantify the relative expression of the target genes using the comparative Ct 
method, the amplification efficiencies between the target genes and the reference genes 
must be very similar (between 90-100%) with an r2 value greater than 0.98 (Livak and 
Schmittgen, 2001).  
 
A 10x serial dilution of template cDNA was used to determine the reaction efficiencies of 
the primer sets of the genes of interest used in this study. Each sample in the dilution series 
was then analysed by qPCR as previously described in appendix 1.8. The Ct values for the 




Ct target gene – Ct reference gene). The delta-Ct value was then plotted against the cDNA dilution 
range. For the comparative Ct method to be applicable in this study, the slope of the 
regression line must be close to zero (Livak and Schmittgen, 2001).  
The qPCR Standard Curve Slope to Efficiency Calculator software 
(http://www.genomics.agilent.com/CalculatorPopupWindow.aspx?CalID=8) was used to 








   
y = -4.156x + 40.33 


















   
   
   
Figure 5.16: Linear analysis of a) Zo1 (r2 = 0.9897; reaction efficiency = 140.41%, n=3), b) 
Aqp1 (r2 = 0.9766; reaction efficiency = 73.94%, n=3), c) Slc4a4 (r2 = 0.9353; reaction 
y = -2.3332x + 42.276 















y = -3.1857x + 34.598 














y = -4.616x + 31.64 



















efficiency = 168.31%, n=3), d) Hprt (r2 = 0.9994; reaction efficiency = 106%, n=3), e) β-
actin (r2 = 0.9812; reaction efficiency = 64.68%, n=3). 
 
1.11 Data analysis 
HID Real-Time PCR Analysis Software version 1.2 (Applied Biosystems) was used to 
analyse all the qPCR data presented in this study. A custom assay was designed using the 
HID Real-Time software package. The custom assay option allows the user to define the 
qPCR reaction parameters and provides a quality control (QC) summary that indicates 
which reactions should be excluded from the analysis (figure 5.17). Quantification cycle 
(Cq) readings were determined using an automatic threshold determined by the HID 
software package. The SYBR channel was used to measure fluorescence in the absence of a 





Figure 5.17: A QC summary of the parameters used to exclude reactions from the analyses, 
as shown in the HID Real-Time PCR Analysis Software program.  
 
NTC and ‘no-RT’ controls (figures 5.18 and 5.19 respectively) resulted in an undetectable 
Cq reading that the software denotes “undeterminable” or primer dimers that were identified 
by a melt curve with a temperature lower than 80°C. 
128 
 
    
Figure 5.18: Melt curve analysis for an Aqp1 NTC control with a melting temperature at 
66.69°C.  
 




1.12 Reference Genes 
Gene expression data must be normalised against reference genes (also referred to as 
internal control genes or housekeeping genes) in order to perform accurate and reliable 
gene expression analyses (De Jonge et al., 2007). A recent study conducted by Shei et al., 
2013 used both β-actin and HPRT as references genes for qPCR analyses in murine corneal 
endothelium and cell culture (Shei et al., 2013). In this study, the expression levels of the 
target genes were normalised against that of the reference genes β-actin and Hprt, which 
rank first and eighth in the list of the 12 most reliable commonly used reference genes (De 
Jonge et al., 2007). 
 
1.13 -ΔΔCt Method 
The Cq values generated by the HID Real-Time PCR Analysis Software version 1.2 
(Applied Biosystems) were analysed using the 2-ΔΔCt method (Livak and Schmittgen, 2001). 
This method identifies the fold-change expression of the target gene relative to the 
reference genes which accounts for basal gene expression levels. Reactions for each target 
gene in each cell line were performed in triplicate and the average Cq for each target gene 
was then normalised against the geometric mean of the two reference genes. The fold-
change in expression was then calculated as follows: 
 
 
Delta Ct = Cq target gene - Cq reference gene 
Delta-delta Ct = delta Cq (target gene) - delta Cq (reference gene) 
Thus, delt-delta Ct (reference gene) = delta Ct (reference gene)-delta Ct (reference gene) = 
0 
Therefore, 2-delta delta Ct of the reference gene = 20=1 






qPCR data were analysed using (IBM) SPSS Statistics Version 21. A one-way ANOVA 
was used to determine the statistical significance of the relative fold change of the target 
genes relative to the reference genes. The assumption that the residuals from the analysis 
are normally distributed was tested using a one-sample Kolmogorov-Smirnov test. A 
Levene’s test was used to test the assumption that the residuals must be homoscedastic. 
These assumptions must be satisfied for the ANOVA to yield valid statistical results. A 
Tukey HSD post-hoc test was used to determine if there was statistical significance in gene 
expression of target genes between different developmental stages. All tests for normality 
were satisfied and significance was determined at p˂0.05. Results are presented as bar 
graphs with error bars that represent the standard deviation of the normalised expression 
calculated from an average of the triplicate values given for each target gene and the two 
reference genes. 
 
2. Ponceau S staining used to detect total protein for western blot analysis. 
 
 
Figure 5.20: Ponceau S image of Aqp1 protein expression at different stages of corneal 
endothelial development. This is a single representative image.   
Total protein was detected by imaging the membrane using the Molecular Marker protocol 






3. Immunocytochemistry  
a) Controls 
For the negative controls, primary and secondary antibodies were substituted by 1x PBS in no-
primary controls and no-secondary controls respectively, to identify non-specific binding of each 
antibody. P13 monolayer and hanging drop negative controls are shown for both Zo1 and Aqp1 as 
representative images for all the cell lines.  
 
 
Figure 5.21: 63x confocal microscopy image showing no-primary antibody control for Zo1 
monolayer cultures. A) DAPI stained cells B) no-primary control C) Merged image. Scale 





Figure 5.22: 63x confocal microscopy image showing no-secondary antibody control for 
Zo1 monolayer cultures. A) DAPI stained cells B) no-secondary control C) Merged image. 
Scale bar is 20 µm. 
 
Figure 5.23: 63x confocal microscopy image showing no-primary antibody control for 
Aqp1 monolayer cultures. A) DAPI stained cells B) no-primary control C) Merged image. 





Figure 5.24: 63x confocal microscopy image showing no-secondary antibody control for 
Aqp1 monolayer cultures. A) DAPI stained cells B) no-secondary control C) Merged 
image. Scale bar is 20 µm. 
 
Figure 5.25: 25x confocal microscopy image showing no-primary antibody control for Zo1 
hanging drop cultures. A) DAPI stained cells B) no-primary control C) Merged image. 





Figure 5.26: 25x confocal microscopy image showing no-secondary antibody control for 
Zo1 hanging drop cultures. A) DAPI stained cells B) no-secondary control C) Merged 
image. Scale bar is 50 µm. 
 
Figure 5.27: 25x confocal microscopy image showing no-primary antibody control for 
Aqp1 hanging drop cultures. A) DAPI stained cells B) no-primary control C) Merged 





Figure 5.28: 25x confocal microscopy image showing no-secondary antibody control for 
Aqp1 hanging drop cultures. A) DAPI stained cells B) no-secondary control C) Merged 
image. Scale bar is 50 µm. 
b) Troubleshooting 
To optimise Zo1 staining for confocal microscopy, Zo1 antibody concentrations ranging 
from 1:50 to 1:1000 as well as various Cy3 incubation times (2, 4, 6 and 24 hours) were 
attempted. Monolayer cultures were also grown in serum free media to assess whether 
protein factors in the serum affected Zo1 expression (Appendix 3b). However, despite this, 
very little Zo1 staining was seen in monolayer culture.  
 
4. Recipes 
4.1 General Recipes  
a) 1M Potassium hydroxide (KOH) 
Reagents Volume (200 mL) 
KOH 11.22 g 
Ultra-pure Water  200 mL 
KOH was dissolved in ultra-pure water and stored at room temperature. Tungsten needles 
used for micro-dissections were sharpened on a wetstone, followed by electrochemical 




b) 70% Ethanol 
Reagents Volume (1 L) 
100% Ethanol 700 mL 
Ultra-pure Water  300 mL 
700 mL 100% ethanol was diluted with 300 mL ultra-pure water.  
 
c) 1x PBS Buffer 
Reagents Volume (1 L) 
KH2PO4 (Merck) 0.24 g 
Na2HPO4 (Merck) 1.44 g  
NaCl (Merck) 8 g 
KCL (Merck) 0.2 g 
Ultra-pure water 450 mL 
The components were dissolved in 800 mL ultra-pure water. The pH was then adjusted to 
pH 7.4. Thereafter, the volume was made up to 1 L with ultra-pure water, autoclaved and 
allowed to cool before it was diluted for use. 
 
d) 1x Trypsin-EDTA Solution 
Reagents Volume (10 mL) 
10x Trypsin 1 mL 
Sodium EDTA  9 mL 
1 part 10x Trypsin was diluted with 9 parts sodium EDTA. 
 
e) Hoechst nuclear stain stock solution 
Reagents Volume (15 mL) 
Hoechst (bis benzimide) (Sigma-Aldrich®) 0.00075 g 
137 
 
 1x PBS (See Appendix 3.1c) 15 mL 
0.00075 g Hoechst was diluted in 15 mL 1x PBS to yield a final concentration of 0.05 
mg/mL. 
Hoechst working solution 
Reagents Volume (100 mL) 
Hoechst stock solution  1 mL 
 1x PBS (See Appendix 3.1c) 99 mL 
1 mL Hoechst stock solution was diluted in 99 mL 1x PBS to yield a final concentration of 





f) Bleach agarose gel 
Ethidium bromide working solution  
Reagents Volume (100 mL) 
Ethidium bromide 500 µl 
1x TBE buffer 
 
100 mL 
The ethidium bromide stock solution was diluted in 1x TBE buffer (1:200) to yield a 0.5 
µg/mL ethidium bromide working solution.  
Bleach agarose gel 
Reagents Volume (40 mL) 
Agarose 0.6 g 
Commercial bleach (3.5% m/v)  680 µl 
10x TAE buffer 40 mL 
0.5 µg/mL ethidium bromide 2.5 µl 
The agarose was weighed using a triple beam balance. The agarose and bleach were added 
to a conical flask and incubated at room temperature for 5 minutes with occasional 
swirling. The solution was melted in 10x TAE buffer in a conical flask using a microwave 
until the agarose was completely dissolved. The solution was allowed to cool briefly before 
ethidium bromide was added in a fume hood.  
 
g) 50x TAE Buffer 
Reagents Volume (100 mL) 
Tris Base 24.2 g 
Glacial acetic acid  5.71 mL  
0.5M EDTA (Merck) 10 mL  
Ultra-pure water  85 mL 
Tris-base; glacial acetic acid; 0.5 M EDTA and ultra-pure water were combined, autoclaved 
and allowed to cool before it was diluted for use. 
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20 mL 10x TAE buffer was diluted with 980 mL autoclaved ultra-pure water to obtain x 
mL 1x TAE buffer.   
 
h) 1.5% Agarose Gel 
Reagents Volume (40 mL) 
Agarose 0.6 g 
1x TBE buffer 40 mL 
0.5 µg/mL ethidium bromide 2.5 µl 
The agarose was weighed using a triple beam balance. It was melted in 1x TBE buffer in a 
conical flask using a microwave until the agarose was completely dissolved. The solution 
was allowed to cool briefly before ethidium bromide was added in a fume hood. 
 
i) 10x TBE Buffer 
Reagents Volume (400 mL) 
Tris Base 43.2 g 
Boric Acid  22 g  
EDTA (Merck) 3.72 g  
Ultra-pure water  320 mL 
Tris base, boric acid and EDTA were dissolved in 320 mL ultra-pure water to make a 10x 
TBE buffer.  
100 mL 10x TBE buffer was diluted in 900 mL ultra-pure water to make a 1x TBE buffer. 
  
4.2 Immunoblot recipes 
a) 10% SDS stock solution 
Reagents Volume (50 mL) 
SDS 5 g 
Ultra-pure water 50 mL 
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SDS was dissolved in ultra-pure water to create a 10% m/v solution. 5 mL of the 10% SDS 
stock solution was diluted with 45 mL ultra-pure water to create a 1% m/v solution when 
needed. 
 
b) Reducing sample treatment buffer/protein loading dye 
Reagents Volume (10 mL) 
10% SDS stock solution (see appendix 3.2a) 4 mL  
4x Stacking gel buffer (see appendix 3.2c) 2.5 mL 
Glycerol 2 mL  
2-Mercaptoethanol (Sigma-Aldrich®) 1 mL 
Bromothymol Blue (Sigma-Aldrich®) 0.1 g 
Ultra-pure water  0.5 mL 
The 4x stacking gel buffer; SDS solution; glycerol and 2-Mercaptoethanol were combined. 
The bromothymol blue was added to the solution which was then mixed until it turned 
blue/purple. The solution was then made up to 10 mL with ultra-pure water.  
 
c) 12.5% SDS PAGE gel 
Solutions 12.5 % Resolving Gel 4% Stacking gel 
30% Bis-acrylamide solution (Bio-
rad) 
3.375 mL 0.47 mL 
4x Running gel buffer 1.875 mL - 
4x Stacking gel buffer - 0.875 mL 
Ultra-pure water 2.099 mL 2.15 mL 
10% SDS 75 µl 35 µl 
15% APS initiator 37.5 µl 17.5 µl 





4x Running gel buffer 
Reagents Volume (50 mL) 
Tris-HCL (Calbiochem) 9.09 g 
Ultra-pure water 50 mL 
Tris-HCL was dissolved in ultra-pure water and the pH was adjusted to pH 8.8 
4x Stacking gel buffer 
Reagents Volume (50 mL) 
Tris-HCL (Calbiochem) 3 g 
Ultra-pure water 50 mL 
Tris-HCL was dissolved in ultra-pure water and the pH was adjusted to pH 6.8 
 
15% ammonium persulfate (APS) initiator solution 
Reagents Volume (500 µL) 
Ammonium persulfate 0.033 g 
Ultra-pure water 500 µL 
Ammonium persulfate was dissolved in ultra-pure water to create a 15% m/v solution.  
1x Electrode buffer  
Reagents Volume (1 L) 
Tris-HCL 3 g 
Glycine (Sigma-Aldrich®)  14.4 g  
SDS 10 mL  
Ultra-pure water  990 mL 
The components were combined in 800 mL ultra-pure water. The pH was adjusted to pH 




d) Protein transfer buffer 
Reagents Volume (1 L) 
Tris-HC 3.03 g 
Glycine (Sigma-Aldrich®)  14.4 g  
Methanol (Merck) 200 mL 
SDS 1 g  
Ultra-pure water  600 mL 
Tris-HCL, glycine and SDS were combined in 600 mL ultra-pure water. Methanol was then 
added to the solution. The pH was adjusted to pH 8.3, after which the volume was adjusted 
to 1 L with ultra-pure water.  
 
e) Tris-Buffered Saline-Tween (TBS-T) 
Reagents Volume (1 L) 
NaCL 8 g 
KCL  0.2 g  
Tris-base 3 g  
Tween-20 1 mL  
Ultra-pure water  800 mL 
NaCl, KCL and Tris-base were combined in 800 mL ultra-pure water. The pH was adjusted 
to pH 7.5, after which the volume was adjusted to 1 L with ultra-pure water. Tween-20 was 
then added to the solution.  
f) 6% Skim milk blocking solution 
Reagents Volume (50 mL) 
Skim milk powder 3 g 
TBS-T (see appendix 3.2f) 50 mL 




g) 1x Ponceau S Stain  
Reagents Volume (500 mL) 
0.1% Ponceau S (Sigma-Aldrich®)  0.5 g 
Glacial acetic acid 5 mL 
Ultra-pure water 495 mL 
The components were dissolved in ultra-pure water and stored in a dedicated container at 
room temperature.  
 
h) 1x Ponceau destain  
Reagents Volume (500 mL) 
1% Glacial acetic acid 5 mL 
Ultra-pure water 495 mL 
1% glacial acetic acid was dissolved in ultra-pure water and stored in a dedicated container 
at room temperature.  
 
4.3 Immunocytochemistry recipes 
 
a) 4% Paraformaldehyde (PFA) 
Reagents Volume (100 mL) 
PFA 4 g 
0.1x PBS 96 mL 
PFA was added to 96 mL 0.1x PBS solution. The solution was heated and stirred on a 
magnetic stirrer at 65°C to dissolve the PFA. Drops of 1N NaOH were used to make the 
solution clear whilst stirring the solution. The solution was filter sterilised through a 0.2 µm 





b) 0.5% Bovine serum albumin (BSA) 
Reagents Volume (100 mL) 
BSA 0.25 g 
1x PBS 50 mL 
BSA was dissolved in 1x PBS. The solution was mixed by vortexing. Fresh BSA was 
prepared for each use.  
 
c) 0.2M TRIS buffer pH 8.5 
Reagents Volume (500 mL) 
TRIS base 12.12 g 
Ultra-pure water 400 mL 
The TRIS base was dissolved in 400 mL ultra-pure water and the pH was adjusted to 8.5. 
Thereafter the volume was made up to 500 mL with ultra-pure water. 
 
d) Mowial with DABCO mountant 
Reagents Volume (100 mL) 
Mowial 40-88 (Sigma-Aldrich®) 8 g 
0.2M TRIS buffer pH 8.5 40 mL 
Glycerol 25 mL 
Ultra-pure water 25 mL 
DABCO D-2522 (Sigma-Aldrich®) 1 g 
The Tris buffer and ultra-pure were water were added into a beaker that was heated to 60°C 
on a magnetic stirrer. The mowial was added to the solution, after which the beaker was 
covered in foil. The mowial was left to dissolve for several hours to form a viscous 
solution. Glycerol and DABCO were added to the viscous solution and heated at 60°C until 
the reagents dissolved. The solution was left to stir on the magnetic stirrer for several hours 
until a homogenous solution was formed. The resultant mountant was then aliquoted in 1.5 
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mL micro-centrifuge tubes and stored in the dark at -20°C. The mowial was brought to 
room temperature for 5-10 minutes before use and slides were stored at 4°C. 
5. Cloning recipes 
 
a) Agar plates 
Reagents Volume (100 mL ± 10 plates) 
Luria agar 2 g 
100 mg/mL Ampicillin  100 µl  
Ultra-pure water 100 mL 
The agar was dissolved in ultra-pure water and autoclaved. The solution was left to cool 
slightly before ampicillin was added. The solution was then swirled gently and poured into 
petri dishes. Agar plates were then stored upside down to prevent condensate forming on 
the agar surface at 4°C.  
 
b) Luria-Bertani (LB) broth 
Reagents Volume (1 L) 
LB broth 40 g 
100 mg/mL Ampicillin  1 mL  
Ultra-pure water 1 L 
The LB broth powder was dissolved in ultra-pure water and autoclaved. The solution was 
left to cool slightly before ampicillin was added. The solution was then swirled gently and 
stored at 4°C.  
 
c) Glycerol stocks 
150 µl aliquots of 100% glycerol were autoclaved in 1.5 mL sterile micro-centrifuge tubes. 
Following overnight growth in LB broth, 850 µl of the cell suspension containing the 
plasmid colonies was transferred into the sterilised glycerol. The solution was mixed gently 
by pipetting and the glycerol stocks were stored at -20°C. 
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d) TE buffer 
1M Tris-base  
Reagents Volume (100 mL) 
TRIS base 12.1 g 
Ultra-pure water 100 mL 
Tris-base was dissolved in 60 mL ultra-pure water. The pH was adjusted to pH 8.0 and the 
total volume was made up to 100 mL with ultra-pure water.  
 
0.5M EDTA 
Reagents Volume (100 mL) 
EDTA 18.6 g 
Ultra-pure water 100 mL 
EDTA was dissolved in 60 mL ultra-pure water. The pH was adjusted to pH 8.0 and the 
total volume was made up to 100 mL with ultra-pure water.  
 
TE buffer 
Reagents Volume (1 L) 
1M Tris-base 10 mL 
0.5M EDTA 2 mL 
Ultra-pure water 990 mL 




e) T7 Sequencing Primers 
 
Figure 5.29: T7 sequencing primers used for conventional PCR to verify that the clones 
contained the siRNA insert. 
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f) 8% Native PAGE gel 
Solutions 8 % Resolving Gel 
30% Bis-acrylamide solution (Bio-rad) 3.375 mL 
4x Running gel buffer 1.875 mL 
4x Stacking gel buffer - 
Ultra-pure water 2.099 mL 
Nuclease free water 75 µl 
15% APS initiator 37.5 µl 
TEMED (Sigma-Aldrich®) 3.75 µl 
 
g) Super Optimal Broth (SOB) with catabolite repression (SOC) 
 
SOB medium  
Reagents Volume (1 L) 
Tryptone 20 g 
Yeast extract 5 g 
NaCL 0.5 g 
Ultra-pure water 1 L 
The components were dissolved in ultra-pure water and autoclaved. 
SOC medium  
Reagents Volume (10 mL) 
SOB medium 10 mL 
1M MgCl2 0.1 mL/0.02 g 
1M MgSO4 0.1 mL/0.012 g 
Glucose (20% w/v) 0.2 mL  
The SOB medium, MgCl2 and MgSO4 were combined and filter sterilised using filter paper. 




6. Cloning results  
We followed the manufacturer’s instructions 
(http://www.youbio.cn/sites/default/files/product/documents/vector/pSilencer3.0-
H1_manual.pdf), annealed the oligonucleotides (Figure 5.29), performed the ligation and 
transformed the plasmid into competent cells. 
  
We then performed a mini-prep of the plasmid and performed PCR using T7 primers 
(Figure 5.31). Because the product leaflet assured that the vector could not re-ligate, we 
assumed any PCR product of the correct size would contain the insert. Sanger sequencing 
revealed this not to be the case as all clones sequenced did not contain any insert and thus 
represented re-ligated clones. 
 
We then repeated the procedure, but this time separated the PCR products and restriction 
digest products on an 8% native PAGE gel (Appendix 3.4e) with greater resolving capacity 
to distinguish the presence of the small oligonucleotide insert in the hope that we had 
previously had bad luck with selection. We also designed a restriction digest to discriminate 
between vector and insert and ran these out on a native PAGE gel. PAGE analysis did not 
reveal any clones containing the insert (Figure 5.32). 
 
Because the oligonucleotide insert is so small (65bp), we were worried that we were 
missing the band because of low yield from mini-prep. We then grew the cells in SOC 
medium and performed a midi-prep. Re-analysis did not reveal the presence of the insert. 
We then re-performed the entire procedure and sent potential clones for sequencing. 
Although there was the presence of an insert in some of the clones, the insert was not 100% 





Figure 5.30: siRNA insert. The annealed oligonucleotides were separated on a 1.5% 
agarose gel to confirm the insert size of 65bp.   
 
 
Figure 5.31: PCR products using T7 primers. The expected product size was 590bp.  
  










Figure 5.32: PCR and restriction digest products separated on an 8% native PAGE gel. 1) 
MW (1Kb); 2) MW (50bp); 3-6) PCR products (590bp); 7-14) restriction digest products. 
Vector size is 4900bp.  The siRNA insert (65bp) was not detected.  
600bp 





Figure 5.33: In silico screen of the sequencing results obtained from BiQ Analyzer 
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